JPH053467B2 - - Google Patents
Info
- Publication number
- JPH053467B2 JPH053467B2 JP7236684A JP7236684A JPH053467B2 JP H053467 B2 JPH053467 B2 JP H053467B2 JP 7236684 A JP7236684 A JP 7236684A JP 7236684 A JP7236684 A JP 7236684A JP H053467 B2 JPH053467 B2 JP H053467B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- acid
- lower alkyl
- aryl
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000003839 salts Chemical class 0.000 claims description 16
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 9
- 125000002947 alkylene group Chemical group 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical class C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 claims description 5
- 125000004450 alkenylene group Chemical group 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims description 3
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 125000001544 thienyl group Chemical group 0.000 claims description 3
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 claims 1
- -1 methoxy, ethoxy, propoxy, butoxy Chemical group 0.000 description 43
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
- 150000001875 compounds Chemical class 0.000 description 34
- 239000000243 solution Substances 0.000 description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- 238000006243 chemical reaction Methods 0.000 description 21
- 239000000203 mixture Substances 0.000 description 20
- 238000004519 manufacturing process Methods 0.000 description 19
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 230000002829 reductive effect Effects 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 11
- 229940118019 malondialdehyde Drugs 0.000 description 11
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 239000000741 silica gel Substances 0.000 description 7
- 229910002027 silica gel Inorganic materials 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 6
- 238000004440 column chromatography Methods 0.000 description 6
- 239000012156 elution solvent Substances 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 210000004623 platelet-rich plasma Anatomy 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 150000008065 acid anhydrides Chemical class 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- 150000004945 aromatic hydrocarbons Chemical group 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000008389 polyethoxylated castor oil Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- 230000000304 vasodilatating effect Effects 0.000 description 4
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 235000011054 acetic acid Nutrition 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000002490 cerebral effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 3
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- 229930182837 (R)-adrenaline Natural products 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- TZDPJNSHSWMCPN-UHFFFAOYSA-N 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid Chemical compound OC(=O)C1=C(C)NC(C)=C(C(O)=O)C1C1=CC=CC([N+]([O-])=O)=C1 TZDPJNSHSWMCPN-UHFFFAOYSA-N 0.000 description 2
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical group C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 2
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 125000004414 alkyl thio group Chemical group 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940030600 antihypertensive agent Drugs 0.000 description 2
- 239000002220 antihypertensive agent Substances 0.000 description 2
- 229960004676 antithrombotic agent Drugs 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- WASQWSOJHCZDFK-UHFFFAOYSA-N diketene Chemical compound C=C1CC(=O)O1 WASQWSOJHCZDFK-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 229960005139 epinephrine Drugs 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- GHLZUHZBBNDWHW-UHFFFAOYSA-N nonanamide Chemical compound CCCCCCCCC(N)=O GHLZUHZBBNDWHW-UHFFFAOYSA-N 0.000 description 2
- 125000001402 nonanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 125000002743 phosphorus functional group Chemical group 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- SIOVKLKJSOKLIF-HJWRWDBZSA-N trimethylsilyl (1z)-n-trimethylsilylethanimidate Chemical compound C[Si](C)(C)OC(/C)=N\[Si](C)(C)C SIOVKLKJSOKLIF-HJWRWDBZSA-N 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- BTGWEKWSISKKFW-NBYYMMLRSA-N (e)-2-methyl-3-[4-(pyridin-3-ylmethyl)phenyl]prop-2-enoic acid;hydrochloride Chemical compound Cl.C1=CC(\C=C(/C)C(O)=O)=CC=C1CC1=CC=CN=C1 BTGWEKWSISKKFW-NBYYMMLRSA-N 0.000 description 1
- NBWPQIFSGTYSCZ-UHFFFAOYSA-N 2-(benzylamino)-1-thiophen-2-ylethanol Chemical compound C=1C=CSC=1C(O)CNCC1=CC=CC=C1 NBWPQIFSGTYSCZ-UHFFFAOYSA-N 0.000 description 1
- XNIOWJUQPMKCIJ-UHFFFAOYSA-N 2-(benzylamino)ethanol Chemical compound OCCNCC1=CC=CC=C1 XNIOWJUQPMKCIJ-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- UECDKJVOYBYWQP-BENRWUELSA-N 2-[benzyl(methyl)amino]ethyl (z)-3-aminobut-2-enoate Chemical compound C/C(N)=C/C(=O)OCCN(C)CC1=CC=CC=C1 UECDKJVOYBYWQP-BENRWUELSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- ZETIVVHRRQLWFW-UHFFFAOYSA-N 3-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=CC(C=O)=C1 ZETIVVHRRQLWFW-UHFFFAOYSA-N 0.000 description 1
- QZTUGIZKIHZFAJ-UHFFFAOYSA-N 3-o-ethyl 5-o-[2-(methylamino)ethyl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCCNC)C1C1=CC=CC([N+]([O-])=O)=C1 QZTUGIZKIHZFAJ-UHFFFAOYSA-N 0.000 description 1
- VYDYFBLSMOGONY-UHFFFAOYSA-N 7-imidazol-1-ylheptanoic acid;hydrochloride Chemical compound Cl.OC(=O)CCCCCCN1C=CN=C1 VYDYFBLSMOGONY-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- CMEUYMGYTODLBO-UHFFFAOYSA-N Cl.OC(=O)CCCCCCCCN1C=CN=C1 Chemical compound Cl.OC(=O)CCCCCCCCN1C=CN=C1 CMEUYMGYTODLBO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- ZBBHBTPTTSWHBA-UHFFFAOYSA-N Nicardipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)CC=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZBBHBTPTTSWHBA-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 229920002685 Polyoxyl 35CastorOil Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 208000006193 Pulmonary infarction Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000906446 Theraps Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000013078 crystal Chemical group 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- KZNICNPSHKQLFF-UHFFFAOYSA-N dihydromaleimide Natural products O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- VXNZUUAINFGPBY-UHFFFAOYSA-N ethyl ethylene Chemical group CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000000268 heptanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000004677 hydrates Chemical group 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 210000001589 microsome Anatomy 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229960001783 nicardipine Drugs 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- POTQIHURRUDRCG-UHFFFAOYSA-N nonanoic acid;hydrochloride Chemical compound Cl.CCCCCCCCC(O)=O POTQIHURRUDRCG-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- QUANRIQJNFHVEU-UHFFFAOYSA-N oxirane;propane-1,2,3-triol Chemical compound C1CO1.OCC(O)CO QUANRIQJNFHVEU-UHFFFAOYSA-N 0.000 description 1
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- MWWATHDPGQKSAR-UHFFFAOYSA-N propyne Chemical group CC#C MWWATHDPGQKSAR-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000007575 pulmonary infarction Effects 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- DDMGAAYEUNWXSI-XVSDJDOKSA-M sodium;(5z,8z,11z,14z)-icosa-5,8,11,14-tetraenoate Chemical compound [Na+].CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC([O-])=O DDMGAAYEUNWXSI-XVSDJDOKSA-M 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
Landscapes
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
æ¬çºæã¯ãäžè¬åŒïŒïŒ
ãåŒäžãR1ããã³R7ã¯åäžãŸãã¯ç°ãªã€ãŠäœ
çŽã¢ã«ãã«åºãïŒR2ããã³R3ã¯åäžãããã¯ç°
ãªã€ãŠãæ°ŽçŽ ååãããã¯äœçŽã¢ã«ãã«ãã¢ãªãŒ
ã«âäœçŽã¢ã«ãã«ãããã²ã³çœ®æã¢ãªãŒã«âäœçŽ
ã¢ã«ãã«ãã¢ãªãŒã«ãŸãã¯ããšãã«åºãïŒR4ã¯
眮æãããŠããŠããããçªçŽ ååãå°ãªããšãïŒ
ã€ä»¥äžãå«ãïŒå¡ãŸãã¯ïŒå¡è€çŽ ç°åŒåºãïŒR5
ã¯çœ®æãããŠããŠãããããšãã«åºãïŒR6ã¯äœ
çŽã¢ã«ã³ãã·ã«ã«ããã«ãäœçŽã¢ã«ã³ãã·âäœçŽ
ã¢ã«ã³ãã·ã«ã«ããã«ãŸãã¯ïŒ®âã¢ãªãŒã«âäœçŽ
ã¢ã«ãã«ââäœçŽã¢ã«ãã«ã¢ããâäœçŽã¢ã«ã³
ãã·ã«ã«ããã«åºãïŒïŒ¡ã¯ã¢ã«ãã¬ã³ãŸãã¯ã¢ã«
ã±ãã¬ã³åºãïŒïŒ¢ã¯è³éŠæçåæ°ŽçŽ ç°ïŒäŸ¡åºãŸã
ã¯çµåæãïŒïŒ€ã¯ã¢ã«ãã¬ã³åºãŸãã¯çµåæãïŒ
ããã³ïœã¯ïŒïŒïŒïŒïŒãŸãã¯ïŒãããããæå³ã
ãã ã§è¡šããããæ°èŠãªïŒïŒïŒâãžãããããªãžã³èª
å°äœããã³ãã®å¡©é¡ã«é¢ããã ãããŠããã®ç®çãšãããšããã¯ãè¡ç®¡æ¡åŒµäœ
çšã®ã¿ãªããè¡å°æ¿åéæå¶äœçšãæããéå§
å€ãè³ããã³å¿è埪ç°é害治çå€äžŠã³ã«æè¡æ å€
ãšããŠæçšãªæ°èŠãªååç©ãæäŸããããšã«ã
ãã åŸæ¥ãïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããã
ãšãã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâ
ãžã«ã«ãã³é žâãžã¡ãã«ãšã¹ãã«ïŒäžè¬åïŒãã
ãšãžãã³ãç±³åœç¹èš±ç¬¬3644627å·ïŒããã³ïŒïŒïŒ
âãžã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒïŒ
âãžãããããªãžã³âïŒïŒïŒâãžã«ã«ãã³é žâïŒ
âãïŒâïŒïŒ®âãã³ãžã«ââã¡ãã«ã¢ããïŒãšã
ã«ããšã¹ãã«âïŒâã¡ãã«ãšã¹ãã«ã»å¡©é žå¡©ïŒäž
è¬åïŒãã«ã«ãžãã³ãç¹å ¬æ55â45075å·ïŒãªã©
ã®ïŒïŒïŒâãžãããããªãžã³èªå°äœãè³åŸªç°é害
ãå¿è埪ç°é害ã®æ²»çå€ãšããŠæçšã§ããããšã
ç¥ãããŠããã ãããããããã¯ãããã匷ãè¡ç®¡æ¡åŒµäœçšã
æããããè³ããã³å¿è埪ç°é害ã®äžå ã§ããè¡
æ ã«å¯Ÿããäœçšã¯ååãªãã®ãšã¯ãããªãã€ãã ãããç¶æ³äžã«ãããŠãæ¬çºæè ãã¯ãåŸæ¥ç¥
ãããŠããïŒïŒïŒâãžãããããªãžã³èªå°äœã®ã«
ã«ããã·ã«åºã«ãäžè¬åŒ ãåŒäžãR2ïŒR3ïŒR4ïŒïŒ¡ïŒïŒ¢ïŒïŒ€ããã³ïœã¯
åèšãããšåæ§ã®æå³ãæããã ã§è¡šããããåºãå°å ¥ããååç©ãããªãã¡ãäž
è¬åŒïŒïŒã§è¡šããããïŒïŒïŒâãžãããããªãž
ã³èªå°äœããã³ãã®å¡©é¡ããè¡ç®¡æ¡åŒµäœçšã®ã¿ãª
ãããåªããè¡å°æ¿åéæå¶äœçšããæããåæ
ã®ç®çãéæãåŸãããšãèŠåºããæ¬çºæãå®æ
ããã«è³ã€ãã 以äžãæ¬çºæååç©ã«ã€ããŠè©³èª¬ããã ãªããæ¬æ现æžäžã§ããäœçŽã¢ã«ãã«ããšã¯ã
ã¡ãã«ããšãã«ãïœâãããã«ãã€ãœãããã«ã
ïœâããã«ãã€ãœããã«ãsecâããã«ãŸãã¯
tertâããã«ã®C1ã4ã¢ã«ãã«åºãããã¢ãªãŒã«ã
ãšã¯ãããšãã°ãããšãã«ããããã«ãªã©ã®åº
ããïŒå¡ãŸãã¯ïŒå¡è³éŠæè€çŽ ç°åŒåºãšã¯ãããš
ãã°ãããšãã«ãããªã«ããããªã«ãããªãžã«ãª
ã©åºããã¢ãªãŒã«âäœçŽã¢ã«ãã«ãšã¯ãããšã
ã°ããã³ãžã«ãããšããã«ãªã©åºãããããã²ã³
ååããšã¯ãããçŽ ååãå¡©çŽ ååãèçŽ ååã
ãšãŠçŽ ååãæå³ããã ãŸããR4ã®çªçŽ ååãå°ãªããšãïŒã€ä»¥äžå«
ãïŒå¡ãŸãã¯ïŒå¡è€çŽ ç°åŒåºãšããŠã¯ãããšã
ã°ããããªã«ãã€ãããŸãªã«ããã©ãŸãªã«ãããª
ãžã«ããã©ãžãã«ãããªããžãã«ãããªããžã
ã«ããªã©ãæãããããããã¯äœçŽã¢ã«ãã«åºã§
眮æãããŠããŠãããã R5ã®ããšãã«åºã¯ãããã²ã³ååããããåºã
ã·ã¢ãåºãã¢ãžãåºãäœçŽã¢ã«ãã«åºãã¢ãªãŒã«
âäœçŽã¢ã«ãã«åºãã¢ãªãŒã«åºãïŒå¡ãŸãã¯ïŒå¡
è³éŠæè€çŽ ç°åŒåºãã¢ã«ã³ãã·åºïŒããšãã°ãã¡
ããã·ããšããã·ãããããã·ããããã·ãªã©ïŒã
ã¢ã«ã¢ã«ã³ãã·åºïŒããšãã°ããã³ãžã«ãªãã·ã
ããšããã«ãªãã·ãïœâã¯ãããã³ãžã«ãªãã·ã
ïœâã¡ããã·ãã³ãžã«ãªãã·ãªã©ïŒãã¢ãªãŒã«ãª
ãã·åºïŒããšãã°ãããšããã·ãããããã·ãïœ
âã¡ãã«ããšããã·ãªã©ïŒãã¢ã«ãã«ããªåºïŒã
ãšãã°ãã¡ãã«ããªããšãã«ããªããããã«ã
ãªãããã«ããªãªã©ïŒãã¢ãªãŒã«ããªåºïŒããšã
ã°ãããšãã«ããªããããã«ããªãïœâã¡ãã«ã
ãšãã«ããªãªã©ïŒãã¢ãªãŒã«âäœçŽã¢ã«ãã«ããª
åºïŒããšãã°ããã³ãžã«ããªãããšããã«ããªã
ïœâã¯ãããã³ãžã«ããªãïœâã¡ããã·ãã³ãžã«
ããªãªã©ïŒãã¢ã«ã³ãã·ã¢ã«ããã«åºïŒããšãã°ã
ã¡ããã·ã«ã«ããã«ããšããã·ã«ã«ããã«ããã
ããã·ã«ã«ããã«ãªã©ïŒãã¢ã«ãã«ã¹ã«ããã«åº
ïŒããšãã°ãã¡ã¿ã³ã¹ã«ããã«ããšã¿ã³ã¹ã«ãã
ã«ããããã³ã¹ã«ããã«ãªã©ïŒãªã©ã®ïŒã€ä»¥äžã®
åºã§çœ®æãããŠããŠãããã R6ã®äœçŽã¢ã«ã³ãã·ã«ã«ããã«åºãšããŠã¯ã
ã¡ããã·ã«ã«ããã«ããšããã·ã«ã«ããã«ããã
ããã·ã«ã«ããã«ããã³ãããã·ã«ã«ããã«ãªã©
ãïŒäœçŽã¢ã«ã³ãã·âäœçŽã¢ã«ã³ãã·ã«ã«ããã«
åºãšããŠã¯ãã¡ããã·ãšããã·ã«ã«ããã«ãã¡ã
ãã·ããããã·ã«ã«ããã«ããšããã·ãšããã·ã«
ã«ããã«ãããããã·ãšããã·ã«ã«ããã«ããã³
ãããã·ãšããã·ã«ã«ããã«ãªã©ãïŒïŒ®âã¢ãªãŒ
ã«âäœçŽã¢ã«ãã«ââäœçŽã¢ã«ãã«ã¢ããâäœ
çŽã¢ã«ã³ãã·ã«ã«ããã«åºãšããŠã¯ãâãã³ãž
ã«ââã¡ãã«ã¢ãããšããã·ã«ã«ããã«ããã³
âãã³ãžã«ââã¡ãã«ã¢ããããããã·ã«ã«
ããã«ãªã©ãæããããã ããã³ïŒ€ã®ã¢ã«ãã¬ã³åºãšããŠã¯ãããšã
ã°ãã¡ãã¬ã³ããšãã¬ã³ãããªã¡ãã¬ã³ãããã©
ã¡ãã¬ã³ããã³ã¿ã¡ãã¬ã³ããããµã¡ãã¬ã³ãã
ãã¿ã¡ãã¬ã³ããªã¯ã¿ã¡ãã¬ã³ãããã¡ãã¬ã³ã
ãã«ã¡ãã¬ã³ããããã¬ã³ããšãã«ãšãã¬ã³ãªã©
ã®C1ã10ã¢ã«ãã¬ã³åºãæããããã®ã¢ã«ã±ã
ã¬ã³åºãšããŠã¯ãããšãã°ãããã¬ã³ããããã
ã¬ã³ãã¡ãã«ããã¬ã³ãªã©ã®C2ã4ã¢ã«ã±ãã¬ã³åº
ãæãããããã®è³éŠæçåæ°ŽçŽ ç°ïŒäŸ¡åºãšã
ãŠã¯ãããšãã°ããã³ãŒã³ãããã¿ã¬ã³ãªã©ã®è³
éŠæçåæ°ŽçŽ ç°ã®ïŒäŸ¡åºãæããããã ãŸããäžè¬åŒïŒïŒã®ïŒïŒïŒâãžãããããªãž
ã³èªå°äœã®å¡©ãšããŠã¯ãå»è¬ãšããŠèš±å®¹ãããå¡©
ã§ããã°ãããããšãã°ãå¡©é žãèåæ°ŽçŽ é žãç¡«
é žããªã³é žãªã©ã®é±é žãšã®å¡©ãã®é žãé ¢é žããã
ã«é žããã¬ã€ã³é žããªã³ãŽé žãé ç³é žãã¢ã¹ãã©
ã®ã³é žãªã©ã®ææ©ã«ã«ãã³é žãšã®å¡©ãã¡ã¿ã³ã¹ã«
ãã³é žããã³ãŒã³ã¹ã«ãã³é žããã«ãšã³ã¹ã«ãã³
é žãããã¿ã¬ã³ã¹ã«ãã³é žãªã©ã®ã¹ã«ãã³é žãšã®
å¡©ãªã©ã®ç¡æ©é žããã³ææ©é žãšã®å¡©ãæããã
ãã ãããŠãæ¬çºæååç©ã«ã¯å åŠç°æ§äœãååšã
ãããïœâãïœâç°æ§äœããã³ã©ã»ãäœã¯ããã
ãæ¬çºæã«å å«ããããŸã幟äœç°æ§äœããã³äºå€
ç°æ§äœãååšããå Žåããããç°æ§äœããã³ãã
ãã®æ··åç©ã®ããããæ¬çºæã«å å«ãããããã
ã«ãæ¬çºæååç©ã«é¢ããå šãŠã®æ°Žåç©ããã³çµ
æ¶åœ¢ãæ¬çºæã«å å«ãããã æ¬çºæã®äžè¬åŒïŒïŒã§è¡šããããïŒïŒïŒâãž
ãããããªãžã³èªå°äœããã³ãã®å¡©é¡ã¯ãããšã
ã°ãã€ãã«ç€ºãæ¹æ³ã«ãã€ãŠè£œé ããããšãã§ã
ãã ãäžèšåŒäžãR1ïŒR2ïŒR3ïŒR4ïŒR5ïŒR6ïŒR7ïŒ
ïŒïŒ¢ïŒïŒ€ããã³ïœã¯åèšãããšåæ§ã®æå³ãæ
ããR3ã¯æ°ŽçŽ ååãææ©ã·ãªã«ãŸãã¯ææ©ãªã³
åºã瀺ãã R3ã«ãããææ©ã·ãªã«ããã³ææ©ãªã³åºãšã
ãŠã¯æ°ŽãŸãã¯ã¢ã«ã³ãŒã«ãªã©ã§åŠçããã°å®¹æã«
è±é¢ããæ§è³ªãæãããã®ã§ããã°ãããããšã
ã°ãïŒCH3ïŒ3SiâãïŒC2H5ïŒ2âãïŒC2H5ïŒ2â
ãªã©ã®åºãæããããã 補æ³1.ã¯ãäžè¬åŒïŒïŒãïŒïŒããã³ïŒïŒã®
ååç©ããéåžžãåå¿ã«æªåœ±é¿ãåãŒããªãææ©
溶åªãããã¯æ°Žã®ååšäžãŸãã¯äžååšäžã«åå¿ã
ãããããã§çšããããææ©æº¶åªãšããŠã¯ããšã
ã°ãã¡ã¿ããŒã«ããšã¿ããŒã«ãã€ãœãããããŒ
ã«ããã¿ããŒã«ããšãã¬ã³ã°ãªã³ãŒã«ãã¡ãã«ã»
ããœã«ããªã©ã®ã¢ã«ã³ãŒã«é¡ããã³ãŒã³ããã«ãš
ã³ãªã©ã®è³éŠæçåæ°ŽçŽ é¡ãïŒïŒïŒâãžã¯ãããš
ã¿ã³ãªã©ã®ããã²ã³åçåæ°ŽçŽ é¡ãããã©ããã
ãã©ã³ããžãªããµã³ãïŒïŒïŒâãžã¡ããã·ãšã¿ã³
ãªã©ã®ãšãŒãã«é¡ãã¢ã»ããããªã«ãªã©ã®ãããª
ã«é¡ãïŒïŒ®âãžã¡ãã«ãã«ã ã¢ãããïŒïŒ®â
ãžã¡ãã«ã¢ã»ãã¢ãããªã©ã®ã¢ããé¡ãªã©ãæã
ããããããææ©æº¶åªãããã¯æ°Žã¯ïŒçš®ä»¥äžãæ··
åããŠäœ¿çšããŠãããã æ¬åå¿ã«ãããŠãäžè¬åŒïŒïŒããã³ïŒïŒã®
ååç©ã®äœ¿çšéã¯ãäžè¬åŒïŒïŒã®ååç©ã«å¯Ÿã
ãããã0.5ã2.0åã¢ã«ã奜ãŸããããŸããåå¿
枩床ã¯30ã150âãåå¿æéã¯ïŒã24æéã奜ãŸ
ããã 補æ³2.ã¯éåžžã®ã«ã«ãã³é žã®ã¢ããååå¿ãšå
æ§ã«å®æœãããããšãã°ãåå¿ã«æªåœ±é¿ãåãŒã
ãªãææ©æº¶åªã®ååšäžãŸãã¯äžååšäžãäžè¬åŒ
ïŒïŒã®ååç©ãšäžè¬åŒïŒïŒã®ååç©ãããã¯
ãã®å¡©ãšããçž®åå€ã®ååšäžã«åå¿ããããããŸ
ãã¯ãäžè¬åŒïŒïŒã®ååç©ãšäžè¬åŒïŒïŒã®å
åç©ã®ã«ã«ããã·ã«åºã«ãããåå¿æ§èªå°äœãã
ãã¯ãã®å¡©ãšãè±é žå€ã®ååšäžãããã¯äžååšäž
ã«åå¿ããããããã§çšããããææ©æº¶åªãšããŠ
ã¯ãããšãã°å¡©åã¡ãã¬ã³ãã¯ãããã«ã ãåå¡©
åççŽ ãïŒïŒïŒâãžã¯ãããšã¿ã³ãªã©ã®ããã²ã³
åçåæ°ŽçŽ é¡ããžãšãã«ãšãŒãã«ãããã©ããã
ãã©ã³ããžãªããµã³ãªã©ã®ãšãŒãã«é¡ãã¢ã»ã
ã³ãã¡ãã«ãšãã«ã±ãã³ãªã©ã®ã±ãã³é¡ãã¢ã»ã
ãããªã«ãªã©ã®ãããªã«é¡ãïŒïŒ®âãžã¡ãã«ã
ã«ã ã¢ãããïŒïŒ®âãžã¡ãã«ã¢ã»ãã¢ãããªã©
ã®ã¢ããé¡ãªã©ãæãããããããã®ææ©æº¶åªã¯
ïŒçš®ä»¥äžãæ··åããŠäœ¿çšããŠãããããŸããçž®å
å€ãšããŠã¯ãããšãã°ãïŒNâ²âãžã·ã¯ããã
ã·ã«ã«ã«ããžã€ãããªã©ã®ïŒ®ïŒNâ²âãžçœ®æã«ã«
ããžã€ãããïŒâãšããã·ã«ã«ããã«âïŒâãš
ããã·âïŒïŒïŒâãžããããããªã³ãªã©ã®è±æ°Žå€
ãªã©ãæããããããŸããäžè¬åŒïŒïŒã®ååç©
ã®ã«ã«ããã·ã«åºã«ãããåå¿æ§èªå°äœãšããŠ
ã¯ãããšãã°ãé žããã²ã³åç©ïŒããšãã°ãé žã¯
ããªããé žãããããªã©ïŒãé žç¡æ°Žç©ïŒããšãã°
äžè¬åŒïŒïŒã®ååç©ã®ïŒååéå¯Ÿç§°é žç¡æ°Žç©ãª
ã©ïŒãæ··åé žç¡æ°Žç©ïŒããšãã°ãçé žã¢ããšãã«
ãšã¹ãã«ãªã©ãšã®æ··åé žç¡æ°Žç©ã掻æ§ãšã¹ãã«
ïŒããšãã°ããžãããããšãã«ãšã¹ãã«ãã·ã¢ã
ã¡ãã«ãšã¹ãã«ãã¹ã¯ã·ã³ã€ãããšã¹ãã«ãªã©ïŒã
掻æ§é žã¢ããïŒããšãã°ãã€ãããŸãŒã«ãªã©ãšã®
ã¢ããïŒãªã©ãæãããããããã«ãŸãè±é žå€ãš
ããŠã¯ãããšãã°ããªãšãã«ã¢ãã³ããžã¡ãã«ã¢
ããªã³ãããªãžã³ãæ°Žé žåã¢ã«ã«ãªãªã©ãæãã
ãããæ¬åå¿ã«ãããäžè¬åŒïŒïŒã®ååç©ãã
ãã¯ãã®ã«ã«ããã·ã«åºã«ãããåå¿æ§èªå°äœã®
å¡©ãšããŠã¯ãããšãã°ãå¡©é žãç¡«é žãç¡é žãªã©ã®
é±é žãããã¯ã®é žãé ¢é žãããããªã³é žãªã©ã®æ
æ©é žãªã©ã®é žããŸãã¯ãããªãŠã ãã«ãªãŠã ãªã©
ã®ã¢ã«ã«ãªéå±ãã«ã«ã·ãŠã ããã°ãã·ãŠã ãªã©
ã®ã¢ã«ã«ãªåé¡éå±ãããªã¡ãã«ã¢ãã³ãããªãš
ãã«ã¢ãã³ãããªãžã³ãªã©ã®ææ©å¡©åºãšã®å¡©ãæ
ããããã æ¬åå¿ã«ãããŠãäžè¬åŒïŒïŒã®ååç©ããã
ã¯ãã®ã«ã«ããã·ã«åºã«ãããåå¿æ§èªå°äœãŸã
ã¯ãã®å¡©ã®äœ¿çšéã¯ãäžè¬åŒïŒïŒã®ååç©ã«å¯Ÿ
ããŠ0.5ãïŒåã¢ã«ã奜ãŸãããå¿ èŠã«å¿ããŠçž®
åå€ã0.5ãïŒåã¢ã«ãè±é žå€ãïŒåã¢ã«ä»¥äžäœ¿
çšããŠãããããªããè±é žå€ã溶åªãšããŠå Œãã
ããããšãã§ãããåå¿æž©åºŠã¯â20ãâ50âãå
å¿æéã¯ïŒåãïŒæéã奜ãŸããã æ¬æ¹æ³ã®åºçºç©è³ªã¯ãããšãã°æ¬¡ã®æ¹æ³ã«ãã€
ãŠè£œé ããããšãã§ããã ããªãã¡ã補æ³1.ã®äžè¬åŒïŒïŒã®ååç©ã¯ã
次ã®åå¿åŒã«åŸã€ãŠãäžè¬åŒïŒïŒã®ååç©ãã
äžè¬åŒïŒïŒã®ååç©ãããã¯ãã®ã«ã«ããã·ã«
åºã«ãããåå¿æ§èªå°äœãŸãã¯ãã®å¡©ãšãã補æ³
2.ã§èª¬æãããšåæ§ã®åå¿æ¡ä»¶ã§ãåå¿ãããŠäž
è¬åŒïŒïŒã®ååç©ãšãªããã€ãã§ããã«ãžã±ã
ã³ãªã©ããããšãã°ãJ.Chem.Soc.ïŒ97ïŒ1978
ïŒ1910ïŒãªã©ã«èšèŒã®æ¡ä»¶ã§ãåå¿ãããããšã«
ãã補é ãããã ãåŒäžãR1ïŒR2ïŒR3ïŒR4ãïŒïŒ¢ïŒïŒ€ããã³
ïœã¯åèšãããšåæ§ã®æå³ãæããã ãŸãã補æ³1.ã®äžè¬åŒïŒïŒã®ååç©ã¯ãäžè¬
åŒïŒïŒã R7COCH2R6 ïŒïŒ ãåŒäžãR6ããã³R7ã¯åèšãããšåæ§ã®æå³
ãæããã ã®ååç©ã«ã¢ã³ã¢ãã¢ããããšãã°ãJ.Am.
Chem.Soc.ïŒ67ïŒ1019ïŒ1945ïŒãªã©ã«èšèŒã®æ¡ä»¶
ã§åå¿ãããããšã«ãã補é ãããã ããã«ãŸãã補æ³2.ã®äžè¬åŒïŒïŒã®ååç©
ã¯ãChem.Pharm.Bull.ïŒ27ïŒ1426â1440ïŒ1979ïŒ
ããã³å28ïŒ2609â2613ïŒ1980ïŒã«èšèŒã®æ¹æ³ã«
ãã€ãŠè£œé ããããšãã§ããã äžèšè£œæ³1.ããã³è£œæ³2.ã§åŸãããäžè¬åŒ
ïŒïŒã®ååç©ã¯ãæœåºãæ¶åºãã«ã©ã ã¯ããã
ã°ã©ãã€ãŒãªã©ã®éåžžã®æ¹æ³ã«ãã€ãŠåé¢ç²Ÿè£œã
ãããšãã§ãããŸãå¿ èŠã«å¿ããŠãèªäœå ¬ç¥ã®å¡©
圢æåå¿ã«ä»ããŠãææã®å¡©é¡ãšããããšãã§ã
ãã ã€ãã«ãæ¬çºæã®ä»£è¡šçååç©ã®è¬çäœçšã瀺
ãã 被æ€ç©è³ª ïŒ è¡ç®¡æ¡åŒµäœçš ã¢ã«ã¢ããïŒHartleyç³»ãéã500ã700ïœãäž
矀ïŒå¹ïŒã®å¿èãæåºããŠãIangendorffã®çæµ
è£ çœ®ã«åãä»ãããçŽ0.5ïŒ è±ãã€ããªã³è¡ãæ·»
å ãã95ïŒ O2ããã³ïŒïŒ CO2ããæãæ··åã¬ã¹ã
éæ°ããKrebs bicarbonate液ãçæµããã被æ€
ç©è³ªããžã¡ãã«ã¹ã«ããã·ãããã³ããªãªãã·ãš
ãã«èèªé žã°ãªã»ã©ã€ããåååïŒ
Cremophorã»ELãã·ã°ã瀟補ãã®å10ïŒ ïŒå®¹
éïŒå«æ氎溶液ã§ïŒmgïŒmlæ¿åºŠã«èª¿è£œããççé£
å¡©æ°Žã§ç®çæ¿åºŠã«çšéããŠã倧åèã«éè¡æ§ã«æ¿
å ¥ããã«ããŠãŒã¬çŽåã®ãŽã 管ãã0.1ml容éã§
æäžãããã€ãã§ã倧åèããå è¡ç®¡ãçæµããŠ
æµåºãã液éã滎æ°èšïŒäžèœæ»Žæ°èšïŒå€ç®è£œäœæ
補ïŒã«ãŠæž¬å®ããããªãã被æ€ç©è³ªæ·»å åã«æ¯ã
ãŠæµéã50ïŒ å¢å ããçšéãED50å€ãšããŠæ±ã
ãããã®çµæãè¡šâïŒã«ç€ºãã
çŽã¢ã«ãã«åºãïŒR2ããã³R3ã¯åäžãããã¯ç°
ãªã€ãŠãæ°ŽçŽ ååãããã¯äœçŽã¢ã«ãã«ãã¢ãªãŒ
ã«âäœçŽã¢ã«ãã«ãããã²ã³çœ®æã¢ãªãŒã«âäœçŽ
ã¢ã«ãã«ãã¢ãªãŒã«ãŸãã¯ããšãã«åºãïŒR4ã¯
眮æãããŠããŠããããçªçŽ ååãå°ãªããšãïŒ
ã€ä»¥äžãå«ãïŒå¡ãŸãã¯ïŒå¡è€çŽ ç°åŒåºãïŒR5
ã¯çœ®æãããŠããŠãããããšãã«åºãïŒR6ã¯äœ
çŽã¢ã«ã³ãã·ã«ã«ããã«ãäœçŽã¢ã«ã³ãã·âäœçŽ
ã¢ã«ã³ãã·ã«ã«ããã«ãŸãã¯ïŒ®âã¢ãªãŒã«âäœçŽ
ã¢ã«ãã«ââäœçŽã¢ã«ãã«ã¢ããâäœçŽã¢ã«ã³
ãã·ã«ã«ããã«åºãïŒïŒ¡ã¯ã¢ã«ãã¬ã³ãŸãã¯ã¢ã«
ã±ãã¬ã³åºãïŒïŒ¢ã¯è³éŠæçåæ°ŽçŽ ç°ïŒäŸ¡åºãŸã
ã¯çµåæãïŒïŒ€ã¯ã¢ã«ãã¬ã³åºãŸãã¯çµåæãïŒ
ããã³ïœã¯ïŒïŒïŒïŒïŒãŸãã¯ïŒãããããæå³ã
ãã ã§è¡šããããæ°èŠãªïŒïŒïŒâãžãããããªãžã³èª
å°äœããã³ãã®å¡©é¡ã«é¢ããã ãããŠããã®ç®çãšãããšããã¯ãè¡ç®¡æ¡åŒµäœ
çšã®ã¿ãªããè¡å°æ¿åéæå¶äœçšãæããéå§
å€ãè³ããã³å¿è埪ç°é害治çå€äžŠã³ã«æè¡æ å€
ãšããŠæçšãªæ°èŠãªååç©ãæäŸããããšã«ã
ãã åŸæ¥ãïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããã
ãšãã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâ
ãžã«ã«ãã³é žâãžã¡ãã«ãšã¹ãã«ïŒäžè¬åïŒãã
ãšãžãã³ãç±³åœç¹èš±ç¬¬3644627å·ïŒããã³ïŒïŒïŒ
âãžã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒïŒ
âãžãããããªãžã³âïŒïŒïŒâãžã«ã«ãã³é žâïŒ
âãïŒâïŒïŒ®âãã³ãžã«ââã¡ãã«ã¢ããïŒãšã
ã«ããšã¹ãã«âïŒâã¡ãã«ãšã¹ãã«ã»å¡©é žå¡©ïŒäž
è¬åïŒãã«ã«ãžãã³ãç¹å ¬æ55â45075å·ïŒãªã©
ã®ïŒïŒïŒâãžãããããªãžã³èªå°äœãè³åŸªç°é害
ãå¿è埪ç°é害ã®æ²»çå€ãšããŠæçšã§ããããšã
ç¥ãããŠããã ãããããããã¯ãããã匷ãè¡ç®¡æ¡åŒµäœçšã
æããããè³ããã³å¿è埪ç°é害ã®äžå ã§ããè¡
æ ã«å¯Ÿããäœçšã¯ååãªãã®ãšã¯ãããªãã€ãã ãããç¶æ³äžã«ãããŠãæ¬çºæè ãã¯ãåŸæ¥ç¥
ãããŠããïŒïŒïŒâãžãããããªãžã³èªå°äœã®ã«
ã«ããã·ã«åºã«ãäžè¬åŒ ãåŒäžãR2ïŒR3ïŒR4ïŒïŒ¡ïŒïŒ¢ïŒïŒ€ããã³ïœã¯
åèšãããšåæ§ã®æå³ãæããã ã§è¡šããããåºãå°å ¥ããååç©ãããªãã¡ãäž
è¬åŒïŒïŒã§è¡šããããïŒïŒïŒâãžãããããªãž
ã³èªå°äœããã³ãã®å¡©é¡ããè¡ç®¡æ¡åŒµäœçšã®ã¿ãª
ãããåªããè¡å°æ¿åéæå¶äœçšããæããåæ
ã®ç®çãéæãåŸãããšãèŠåºããæ¬çºæãå®æ
ããã«è³ã€ãã 以äžãæ¬çºæååç©ã«ã€ããŠè©³èª¬ããã ãªããæ¬æ现æžäžã§ããäœçŽã¢ã«ãã«ããšã¯ã
ã¡ãã«ããšãã«ãïœâãããã«ãã€ãœãããã«ã
ïœâããã«ãã€ãœããã«ãsecâããã«ãŸãã¯
tertâããã«ã®C1ã4ã¢ã«ãã«åºãããã¢ãªãŒã«ã
ãšã¯ãããšãã°ãããšãã«ããããã«ãªã©ã®åº
ããïŒå¡ãŸãã¯ïŒå¡è³éŠæè€çŽ ç°åŒåºãšã¯ãããš
ãã°ãããšãã«ãããªã«ããããªã«ãããªãžã«ãª
ã©åºããã¢ãªãŒã«âäœçŽã¢ã«ãã«ãšã¯ãããšã
ã°ããã³ãžã«ãããšããã«ãªã©åºãããããã²ã³
ååããšã¯ãããçŽ ååãå¡©çŽ ååãèçŽ ååã
ãšãŠçŽ ååãæå³ããã ãŸããR4ã®çªçŽ ååãå°ãªããšãïŒã€ä»¥äžå«
ãïŒå¡ãŸãã¯ïŒå¡è€çŽ ç°åŒåºãšããŠã¯ãããšã
ã°ããããªã«ãã€ãããŸãªã«ããã©ãŸãªã«ãããª
ãžã«ããã©ãžãã«ãããªããžãã«ãããªããžã
ã«ããªã©ãæãããããããã¯äœçŽã¢ã«ãã«åºã§
眮æãããŠããŠãããã R5ã®ããšãã«åºã¯ãããã²ã³ååããããåºã
ã·ã¢ãåºãã¢ãžãåºãäœçŽã¢ã«ãã«åºãã¢ãªãŒã«
âäœçŽã¢ã«ãã«åºãã¢ãªãŒã«åºãïŒå¡ãŸãã¯ïŒå¡
è³éŠæè€çŽ ç°åŒåºãã¢ã«ã³ãã·åºïŒããšãã°ãã¡
ããã·ããšããã·ãããããã·ããããã·ãªã©ïŒã
ã¢ã«ã¢ã«ã³ãã·åºïŒããšãã°ããã³ãžã«ãªãã·ã
ããšããã«ãªãã·ãïœâã¯ãããã³ãžã«ãªãã·ã
ïœâã¡ããã·ãã³ãžã«ãªãã·ãªã©ïŒãã¢ãªãŒã«ãª
ãã·åºïŒããšãã°ãããšããã·ãããããã·ãïœ
âã¡ãã«ããšããã·ãªã©ïŒãã¢ã«ãã«ããªåºïŒã
ãšãã°ãã¡ãã«ããªããšãã«ããªããããã«ã
ãªãããã«ããªãªã©ïŒãã¢ãªãŒã«ããªåºïŒããšã
ã°ãããšãã«ããªããããã«ããªãïœâã¡ãã«ã
ãšãã«ããªãªã©ïŒãã¢ãªãŒã«âäœçŽã¢ã«ãã«ããª
åºïŒããšãã°ããã³ãžã«ããªãããšããã«ããªã
ïœâã¯ãããã³ãžã«ããªãïœâã¡ããã·ãã³ãžã«
ããªãªã©ïŒãã¢ã«ã³ãã·ã¢ã«ããã«åºïŒããšãã°ã
ã¡ããã·ã«ã«ããã«ããšããã·ã«ã«ããã«ããã
ããã·ã«ã«ããã«ãªã©ïŒãã¢ã«ãã«ã¹ã«ããã«åº
ïŒããšãã°ãã¡ã¿ã³ã¹ã«ããã«ããšã¿ã³ã¹ã«ãã
ã«ããããã³ã¹ã«ããã«ãªã©ïŒãªã©ã®ïŒã€ä»¥äžã®
åºã§çœ®æãããŠããŠãããã R6ã®äœçŽã¢ã«ã³ãã·ã«ã«ããã«åºãšããŠã¯ã
ã¡ããã·ã«ã«ããã«ããšããã·ã«ã«ããã«ããã
ããã·ã«ã«ããã«ããã³ãããã·ã«ã«ããã«ãªã©
ãïŒäœçŽã¢ã«ã³ãã·âäœçŽã¢ã«ã³ãã·ã«ã«ããã«
åºãšããŠã¯ãã¡ããã·ãšããã·ã«ã«ããã«ãã¡ã
ãã·ããããã·ã«ã«ããã«ããšããã·ãšããã·ã«
ã«ããã«ãããããã·ãšããã·ã«ã«ããã«ããã³
ãããã·ãšããã·ã«ã«ããã«ãªã©ãïŒïŒ®âã¢ãªãŒ
ã«âäœçŽã¢ã«ãã«ââäœçŽã¢ã«ãã«ã¢ããâäœ
çŽã¢ã«ã³ãã·ã«ã«ããã«åºãšããŠã¯ãâãã³ãž
ã«ââã¡ãã«ã¢ãããšããã·ã«ã«ããã«ããã³
âãã³ãžã«ââã¡ãã«ã¢ããããããã·ã«ã«
ããã«ãªã©ãæããããã ããã³ïŒ€ã®ã¢ã«ãã¬ã³åºãšããŠã¯ãããšã
ã°ãã¡ãã¬ã³ããšãã¬ã³ãããªã¡ãã¬ã³ãããã©
ã¡ãã¬ã³ããã³ã¿ã¡ãã¬ã³ããããµã¡ãã¬ã³ãã
ãã¿ã¡ãã¬ã³ããªã¯ã¿ã¡ãã¬ã³ãããã¡ãã¬ã³ã
ãã«ã¡ãã¬ã³ããããã¬ã³ããšãã«ãšãã¬ã³ãªã©
ã®C1ã10ã¢ã«ãã¬ã³åºãæããããã®ã¢ã«ã±ã
ã¬ã³åºãšããŠã¯ãããšãã°ãããã¬ã³ããããã
ã¬ã³ãã¡ãã«ããã¬ã³ãªã©ã®C2ã4ã¢ã«ã±ãã¬ã³åº
ãæãããããã®è³éŠæçåæ°ŽçŽ ç°ïŒäŸ¡åºãšã
ãŠã¯ãããšãã°ããã³ãŒã³ãããã¿ã¬ã³ãªã©ã®è³
éŠæçåæ°ŽçŽ ç°ã®ïŒäŸ¡åºãæããããã ãŸããäžè¬åŒïŒïŒã®ïŒïŒïŒâãžãããããªãž
ã³èªå°äœã®å¡©ãšããŠã¯ãå»è¬ãšããŠèš±å®¹ãããå¡©
ã§ããã°ãããããšãã°ãå¡©é žãèåæ°ŽçŽ é žãç¡«
é žããªã³é žãªã©ã®é±é žãšã®å¡©ãã®é žãé ¢é žããã
ã«é žããã¬ã€ã³é žããªã³ãŽé žãé ç³é žãã¢ã¹ãã©
ã®ã³é žãªã©ã®ææ©ã«ã«ãã³é žãšã®å¡©ãã¡ã¿ã³ã¹ã«
ãã³é žããã³ãŒã³ã¹ã«ãã³é žããã«ãšã³ã¹ã«ãã³
é žãããã¿ã¬ã³ã¹ã«ãã³é žãªã©ã®ã¹ã«ãã³é žãšã®
å¡©ãªã©ã®ç¡æ©é žããã³ææ©é žãšã®å¡©ãæããã
ãã ãããŠãæ¬çºæååç©ã«ã¯å åŠç°æ§äœãååšã
ãããïœâãïœâç°æ§äœããã³ã©ã»ãäœã¯ããã
ãæ¬çºæã«å å«ããããŸã幟äœç°æ§äœããã³äºå€
ç°æ§äœãååšããå Žåããããç°æ§äœããã³ãã
ãã®æ··åç©ã®ããããæ¬çºæã«å å«ãããããã
ã«ãæ¬çºæååç©ã«é¢ããå šãŠã®æ°Žåç©ããã³çµ
æ¶åœ¢ãæ¬çºæã«å å«ãããã æ¬çºæã®äžè¬åŒïŒïŒã§è¡šããããïŒïŒïŒâãž
ãããããªãžã³èªå°äœããã³ãã®å¡©é¡ã¯ãããšã
ã°ãã€ãã«ç€ºãæ¹æ³ã«ãã€ãŠè£œé ããããšãã§ã
ãã ãäžèšåŒäžãR1ïŒR2ïŒR3ïŒR4ïŒR5ïŒR6ïŒR7ïŒ
ïŒïŒ¢ïŒïŒ€ããã³ïœã¯åèšãããšåæ§ã®æå³ãæ
ããR3ã¯æ°ŽçŽ ååãææ©ã·ãªã«ãŸãã¯ææ©ãªã³
åºã瀺ãã R3ã«ãããææ©ã·ãªã«ããã³ææ©ãªã³åºãšã
ãŠã¯æ°ŽãŸãã¯ã¢ã«ã³ãŒã«ãªã©ã§åŠçããã°å®¹æã«
è±é¢ããæ§è³ªãæãããã®ã§ããã°ãããããšã
ã°ãïŒCH3ïŒ3SiâãïŒC2H5ïŒ2âãïŒC2H5ïŒ2â
ãªã©ã®åºãæããããã 補æ³1.ã¯ãäžè¬åŒïŒïŒãïŒïŒããã³ïŒïŒã®
ååç©ããéåžžãåå¿ã«æªåœ±é¿ãåãŒããªãææ©
溶åªãããã¯æ°Žã®ååšäžãŸãã¯äžååšäžã«åå¿ã
ãããããã§çšããããææ©æº¶åªãšããŠã¯ããšã
ã°ãã¡ã¿ããŒã«ããšã¿ããŒã«ãã€ãœãããããŒ
ã«ããã¿ããŒã«ããšãã¬ã³ã°ãªã³ãŒã«ãã¡ãã«ã»
ããœã«ããªã©ã®ã¢ã«ã³ãŒã«é¡ããã³ãŒã³ããã«ãš
ã³ãªã©ã®è³éŠæçåæ°ŽçŽ é¡ãïŒïŒïŒâãžã¯ãããš
ã¿ã³ãªã©ã®ããã²ã³åçåæ°ŽçŽ é¡ãããã©ããã
ãã©ã³ããžãªããµã³ãïŒïŒïŒâãžã¡ããã·ãšã¿ã³
ãªã©ã®ãšãŒãã«é¡ãã¢ã»ããããªã«ãªã©ã®ãããª
ã«é¡ãïŒïŒ®âãžã¡ãã«ãã«ã ã¢ãããïŒïŒ®â
ãžã¡ãã«ã¢ã»ãã¢ãããªã©ã®ã¢ããé¡ãªã©ãæã
ããããããææ©æº¶åªãããã¯æ°Žã¯ïŒçš®ä»¥äžãæ··
åããŠäœ¿çšããŠãããã æ¬åå¿ã«ãããŠãäžè¬åŒïŒïŒããã³ïŒïŒã®
ååç©ã®äœ¿çšéã¯ãäžè¬åŒïŒïŒã®ååç©ã«å¯Ÿã
ãããã0.5ã2.0åã¢ã«ã奜ãŸããããŸããåå¿
枩床ã¯30ã150âãåå¿æéã¯ïŒã24æéã奜ãŸ
ããã 補æ³2.ã¯éåžžã®ã«ã«ãã³é žã®ã¢ããååå¿ãšå
æ§ã«å®æœãããããšãã°ãåå¿ã«æªåœ±é¿ãåãŒã
ãªãææ©æº¶åªã®ååšäžãŸãã¯äžååšäžãäžè¬åŒ
ïŒïŒã®ååç©ãšäžè¬åŒïŒïŒã®ååç©ãããã¯
ãã®å¡©ãšããçž®åå€ã®ååšäžã«åå¿ããããããŸ
ãã¯ãäžè¬åŒïŒïŒã®ååç©ãšäžè¬åŒïŒïŒã®å
åç©ã®ã«ã«ããã·ã«åºã«ãããåå¿æ§èªå°äœãã
ãã¯ãã®å¡©ãšãè±é žå€ã®ååšäžãããã¯äžååšäž
ã«åå¿ããããããã§çšããããææ©æº¶åªãšããŠ
ã¯ãããšãã°å¡©åã¡ãã¬ã³ãã¯ãããã«ã ãåå¡©
åççŽ ãïŒïŒïŒâãžã¯ãããšã¿ã³ãªã©ã®ããã²ã³
åçåæ°ŽçŽ é¡ããžãšãã«ãšãŒãã«ãããã©ããã
ãã©ã³ããžãªããµã³ãªã©ã®ãšãŒãã«é¡ãã¢ã»ã
ã³ãã¡ãã«ãšãã«ã±ãã³ãªã©ã®ã±ãã³é¡ãã¢ã»ã
ãããªã«ãªã©ã®ãããªã«é¡ãïŒïŒ®âãžã¡ãã«ã
ã«ã ã¢ãããïŒïŒ®âãžã¡ãã«ã¢ã»ãã¢ãããªã©
ã®ã¢ããé¡ãªã©ãæãããããããã®ææ©æº¶åªã¯
ïŒçš®ä»¥äžãæ··åããŠäœ¿çšããŠãããããŸããçž®å
å€ãšããŠã¯ãããšãã°ãïŒNâ²âãžã·ã¯ããã
ã·ã«ã«ã«ããžã€ãããªã©ã®ïŒ®ïŒNâ²âãžçœ®æã«ã«
ããžã€ãããïŒâãšããã·ã«ã«ããã«âïŒâãš
ããã·âïŒïŒïŒâãžããããããªã³ãªã©ã®è±æ°Žå€
ãªã©ãæããããããŸããäžè¬åŒïŒïŒã®ååç©
ã®ã«ã«ããã·ã«åºã«ãããåå¿æ§èªå°äœãšããŠ
ã¯ãããšãã°ãé žããã²ã³åç©ïŒããšãã°ãé žã¯
ããªããé žãããããªã©ïŒãé žç¡æ°Žç©ïŒããšãã°
äžè¬åŒïŒïŒã®ååç©ã®ïŒååéå¯Ÿç§°é žç¡æ°Žç©ãª
ã©ïŒãæ··åé žç¡æ°Žç©ïŒããšãã°ãçé žã¢ããšãã«
ãšã¹ãã«ãªã©ãšã®æ··åé žç¡æ°Žç©ã掻æ§ãšã¹ãã«
ïŒããšãã°ããžãããããšãã«ãšã¹ãã«ãã·ã¢ã
ã¡ãã«ãšã¹ãã«ãã¹ã¯ã·ã³ã€ãããšã¹ãã«ãªã©ïŒã
掻æ§é žã¢ããïŒããšãã°ãã€ãããŸãŒã«ãªã©ãšã®
ã¢ããïŒãªã©ãæãããããããã«ãŸãè±é žå€ãš
ããŠã¯ãããšãã°ããªãšãã«ã¢ãã³ããžã¡ãã«ã¢
ããªã³ãããªãžã³ãæ°Žé žåã¢ã«ã«ãªãªã©ãæãã
ãããæ¬åå¿ã«ãããäžè¬åŒïŒïŒã®ååç©ãã
ãã¯ãã®ã«ã«ããã·ã«åºã«ãããåå¿æ§èªå°äœã®
å¡©ãšããŠã¯ãããšãã°ãå¡©é žãç¡«é žãç¡é žãªã©ã®
é±é žãããã¯ã®é žãé ¢é žãããããªã³é žãªã©ã®æ
æ©é žãªã©ã®é žããŸãã¯ãããªãŠã ãã«ãªãŠã ãªã©
ã®ã¢ã«ã«ãªéå±ãã«ã«ã·ãŠã ããã°ãã·ãŠã ãªã©
ã®ã¢ã«ã«ãªåé¡éå±ãããªã¡ãã«ã¢ãã³ãããªãš
ãã«ã¢ãã³ãããªãžã³ãªã©ã®ææ©å¡©åºãšã®å¡©ãæ
ããããã æ¬åå¿ã«ãããŠãäžè¬åŒïŒïŒã®ååç©ããã
ã¯ãã®ã«ã«ããã·ã«åºã«ãããåå¿æ§èªå°äœãŸã
ã¯ãã®å¡©ã®äœ¿çšéã¯ãäžè¬åŒïŒïŒã®ååç©ã«å¯Ÿ
ããŠ0.5ãïŒåã¢ã«ã奜ãŸãããå¿ èŠã«å¿ããŠçž®
åå€ã0.5ãïŒåã¢ã«ãè±é žå€ãïŒåã¢ã«ä»¥äžäœ¿
çšããŠãããããªããè±é žå€ã溶åªãšããŠå Œãã
ããããšãã§ãããåå¿æž©åºŠã¯â20ãâ50âãå
å¿æéã¯ïŒåãïŒæéã奜ãŸããã æ¬æ¹æ³ã®åºçºç©è³ªã¯ãããšãã°æ¬¡ã®æ¹æ³ã«ãã€
ãŠè£œé ããããšãã§ããã ããªãã¡ã補æ³1.ã®äžè¬åŒïŒïŒã®ååç©ã¯ã
次ã®åå¿åŒã«åŸã€ãŠãäžè¬åŒïŒïŒã®ååç©ãã
äžè¬åŒïŒïŒã®ååç©ãããã¯ãã®ã«ã«ããã·ã«
åºã«ãããåå¿æ§èªå°äœãŸãã¯ãã®å¡©ãšãã補æ³
2.ã§èª¬æãããšåæ§ã®åå¿æ¡ä»¶ã§ãåå¿ãããŠäž
è¬åŒïŒïŒã®ååç©ãšãªããã€ãã§ããã«ãžã±ã
ã³ãªã©ããããšãã°ãJ.Chem.Soc.ïŒ97ïŒ1978
ïŒ1910ïŒãªã©ã«èšèŒã®æ¡ä»¶ã§ãåå¿ãããããšã«
ãã補é ãããã ãåŒäžãR1ïŒR2ïŒR3ïŒR4ãïŒïŒ¢ïŒïŒ€ããã³
ïœã¯åèšãããšåæ§ã®æå³ãæããã ãŸãã補æ³1.ã®äžè¬åŒïŒïŒã®ååç©ã¯ãäžè¬
åŒïŒïŒã R7COCH2R6 ïŒïŒ ãåŒäžãR6ããã³R7ã¯åèšãããšåæ§ã®æå³
ãæããã ã®ååç©ã«ã¢ã³ã¢ãã¢ããããšãã°ãJ.Am.
Chem.Soc.ïŒ67ïŒ1019ïŒ1945ïŒãªã©ã«èšèŒã®æ¡ä»¶
ã§åå¿ãããããšã«ãã補é ãããã ããã«ãŸãã補æ³2.ã®äžè¬åŒïŒïŒã®ååç©
ã¯ãChem.Pharm.Bull.ïŒ27ïŒ1426â1440ïŒ1979ïŒ
ããã³å28ïŒ2609â2613ïŒ1980ïŒã«èšèŒã®æ¹æ³ã«
ãã€ãŠè£œé ããããšãã§ããã äžèšè£œæ³1.ããã³è£œæ³2.ã§åŸãããäžè¬åŒ
ïŒïŒã®ååç©ã¯ãæœåºãæ¶åºãã«ã©ã ã¯ããã
ã°ã©ãã€ãŒãªã©ã®éåžžã®æ¹æ³ã«ãã€ãŠåé¢ç²Ÿè£œã
ãããšãã§ãããŸãå¿ èŠã«å¿ããŠãèªäœå ¬ç¥ã®å¡©
圢æåå¿ã«ä»ããŠãææã®å¡©é¡ãšããããšãã§ã
ãã ã€ãã«ãæ¬çºæã®ä»£è¡šçååç©ã®è¬çäœçšã瀺
ãã 被æ€ç©è³ª ïŒ è¡ç®¡æ¡åŒµäœçš ã¢ã«ã¢ããïŒHartleyç³»ãéã500ã700ïœãäž
矀ïŒå¹ïŒã®å¿èãæåºããŠãIangendorffã®çæµ
è£ çœ®ã«åãä»ãããçŽ0.5ïŒ è±ãã€ããªã³è¡ãæ·»
å ãã95ïŒ O2ããã³ïŒïŒ CO2ããæãæ··åã¬ã¹ã
éæ°ããKrebs bicarbonate液ãçæµããã被æ€
ç©è³ªããžã¡ãã«ã¹ã«ããã·ãããã³ããªãªãã·ãš
ãã«èèªé žã°ãªã»ã©ã€ããåååïŒ
Cremophorã»ELãã·ã°ã瀟補ãã®å10ïŒ ïŒå®¹
éïŒå«æ氎溶液ã§ïŒmgïŒmlæ¿åºŠã«èª¿è£œããççé£
å¡©æ°Žã§ç®çæ¿åºŠã«çšéããŠã倧åèã«éè¡æ§ã«æ¿
å ¥ããã«ããŠãŒã¬çŽåã®ãŽã 管ãã0.1ml容éã§
æäžãããã€ãã§ã倧åèããå è¡ç®¡ãçæµããŠ
æµåºãã液éã滎æ°èšïŒäžèœæ»Žæ°èšïŒå€ç®è£œäœæ
補ïŒã«ãŠæž¬å®ããããªãã被æ€ç©è³ªæ·»å åã«æ¯ã
ãŠæµéã50ïŒ å¢å ããçšéãED50å€ãšããŠæ±ã
ãããã®çµæãè¡šâïŒã«ç€ºãã
ãè¡šã
ïŒ ããã³ãããµã³åæé
µçŽ é»å®³äœçš
(i) in vitroããã³ãžã¢ã«ãããïŒMDAïŒ
ç£çæå¶äœçš
ãŠãµã®ïŒæ¥æ¬çœè²çš®ãéã2.5ã3.5KgãäžçŸ€ïŒ
å¹ïŒã®1.1Ã109ïŒmlã®å€è¡å°æ¿è¡æŒ¿ïŒPRPïŒ1.8
mlã«è¢«æ€ç©è³ªæº¶æ¶²ããžã¡ãã«ã¹ã«ããã·ãããã³
Cremophorã»ELã®å10ïŒ ïŒå®¹éïŒå«æ氎溶液ã§
10-2ïŒã«èª¿è£œããççé£å¡©æ°Žã§ç®çæ¿åºŠã«çšéã
ãã0.2mlãå ãã37âã§ïŒåéãã¬ã€ã³ããŠãŒ
ããŒã·ãšã³ãããã€ãã§ã10mMã¢ã©ããã³é žã
ããªãŠã 0.1mlãå ããïŒåéåå¿ãããåŸãã€
ã³ãã¡ã¿ã·ã³ãå ããŠåå¿ãåæ¢ããããåå¿æ¶²
ãé€èçœåŠçããTBAïŒããªãã«ããã«é žïŒè©Šè¬
ãšåå¿ãããåŸãïœâãã¿ããŒã«ïŒmlã§æœåºã
ãããã®æœåºæ¶²ãæ¯è²å®éïŒÎ»ïŒ532nmïŒããŠ
MDAç£çéã枬å®ãããåäžåäœããåŸãä¹è¡
å°æ¿è¡æŒ¿ïŒPPPïŒã«ã€ããŠãåæ§ã«æäœããŠ
MDAç£çéã枬å®ãã次åŒããMDAç£çæå¶
çãæ±ãã40ïŒ æå¶ãã被æ€ç©è³ªæ¿åºŠãIC40
ïŒïŒïŒããæ±ããã MDAç£çæå¶çïŒïŒ ïŒ ïŒïŒïŒâ被æ€ç©è³ªã®PRPã§ã®MDAç£çéâ被æ€ç©è³ªã®PPP
ã§ã®MDAç£çéïŒã³ã³ãããŒã«ã®PRPã§ã®MDAç£çéâã³
ã³ãããŒã«ã®PPPã§ã®MDAç£çéïŒÃ100 (ii) ã·ã¯ããªãã·ã²ããŒãŒé»å®³äœçš ããªã¹âå¡©é žç·©è¡æ¶²ïŒPH7.7ïŒã«ãŠãµã® ïŒæ¥
æ¬çœè²çš®ãéã2.5ã3.5KgãäžçŸ€ïŒå¹ïŒè é«è³ªã
ã¯ããŸãŒã ïŒmgããšããããªã³7.5mMãã°ã«ã¿
ããªã³5mMããã³è¢«æ€ç©è³ªæº¶æ¶²ããžã¡ãã«ã¹ã«
ããã·ãããã³Cremophorã»ELãæçµæ¿åºŠãšã
ãŠå0.01ïŒ ïŒå®¹éïŒå«ãã100ÎŒãå ãå šéãïŒ
mlãšãããã€ãã§ã14Câã¢ã©ããã³é žãããªãŠ
ã ïŒ16mMã0.04ÎŒCiïŒã®ãšã¿ããŒã«æº¶æ¶²ãå ãã
15åéã€ã³ããŠããŒã·ãšã³ããã次ãã§ã1Nâ
å¡©é žãå ããŠåå¿ãåæ¢ãããé ¢é žãšãã«1.5ml
ã§æœåºãããæœåºæ¶²ãæžå§äžã«æ¿çž®ããèå±€ã¯ã
ããã°ã©ãã€ãŒãã¡ã«ã¯ç€Ÿè£œã·ãªã«ã²ã«60F254ã
å±é溶åªïŒé ¢é žãšãã«ïŒã¢ã»ãã³ïŒé ¢é žïŒ90ïŒ
10ïŒïŒïŒå®¹éæ¯ïŒãã§å±éãããPGE2ã®åç»ãå
åãã液äœã·ã³ãã¬ãŒã·ãšã³ã«ãŠã³ã¿ãŒã§PGE2
çæéã枬å®ãããã·ã¯ããªãã·ã²ããŒãŒé»å®³äœ
çšã¯ã³ã³ãããŒã«ã®PGE2ã®çæéã«å¯Ÿããæå¶
çããæ±ããããã®çµæãè¡šâïŒã«ç€ºãã
å¹ïŒã®1.1Ã109ïŒmlã®å€è¡å°æ¿è¡æŒ¿ïŒPRPïŒ1.8
mlã«è¢«æ€ç©è³ªæº¶æ¶²ããžã¡ãã«ã¹ã«ããã·ãããã³
Cremophorã»ELã®å10ïŒ ïŒå®¹éïŒå«æ氎溶液ã§
10-2ïŒã«èª¿è£œããççé£å¡©æ°Žã§ç®çæ¿åºŠã«çšéã
ãã0.2mlãå ãã37âã§ïŒåéãã¬ã€ã³ããŠãŒ
ããŒã·ãšã³ãããã€ãã§ã10mMã¢ã©ããã³é žã
ããªãŠã 0.1mlãå ããïŒåéåå¿ãããåŸãã€
ã³ãã¡ã¿ã·ã³ãå ããŠåå¿ãåæ¢ããããåå¿æ¶²
ãé€èçœåŠçããTBAïŒããªãã«ããã«é žïŒè©Šè¬
ãšåå¿ãããåŸãïœâãã¿ããŒã«ïŒmlã§æœåºã
ãããã®æœåºæ¶²ãæ¯è²å®éïŒÎ»ïŒ532nmïŒããŠ
MDAç£çéã枬å®ãããåäžåäœããåŸãä¹è¡
å°æ¿è¡æŒ¿ïŒPPPïŒã«ã€ããŠãåæ§ã«æäœããŠ
MDAç£çéã枬å®ãã次åŒããMDAç£çæå¶
çãæ±ãã40ïŒ æå¶ãã被æ€ç©è³ªæ¿åºŠãIC40
ïŒïŒïŒããæ±ããã MDAç£çæå¶çïŒïŒ ïŒ ïŒïŒïŒâ被æ€ç©è³ªã®PRPã§ã®MDAç£çéâ被æ€ç©è³ªã®PPP
ã§ã®MDAç£çéïŒã³ã³ãããŒã«ã®PRPã§ã®MDAç£çéâã³
ã³ãããŒã«ã®PPPã§ã®MDAç£çéïŒÃ100 (ii) ã·ã¯ããªãã·ã²ããŒãŒé»å®³äœçš ããªã¹âå¡©é žç·©è¡æ¶²ïŒPH7.7ïŒã«ãŠãµã® ïŒæ¥
æ¬çœè²çš®ãéã2.5ã3.5KgãäžçŸ€ïŒå¹ïŒè é«è³ªã
ã¯ããŸãŒã ïŒmgããšããããªã³7.5mMãã°ã«ã¿
ããªã³5mMããã³è¢«æ€ç©è³ªæº¶æ¶²ããžã¡ãã«ã¹ã«
ããã·ãããã³Cremophorã»ELãæçµæ¿åºŠãšã
ãŠå0.01ïŒ ïŒå®¹éïŒå«ãã100ÎŒãå ãå šéãïŒ
mlãšãããã€ãã§ã14Câã¢ã©ããã³é žãããªãŠ
ã ïŒ16mMã0.04ÎŒCiïŒã®ãšã¿ããŒã«æº¶æ¶²ãå ãã
15åéã€ã³ããŠããŒã·ãšã³ããã次ãã§ã1Nâ
å¡©é žãå ããŠåå¿ãåæ¢ãããé ¢é žãšãã«1.5ml
ã§æœåºãããæœåºæ¶²ãæžå§äžã«æ¿çž®ããèå±€ã¯ã
ããã°ã©ãã€ãŒãã¡ã«ã¯ç€Ÿè£œã·ãªã«ã²ã«60F254ã
å±é溶åªïŒé ¢é žãšãã«ïŒã¢ã»ãã³ïŒé ¢é žïŒ90ïŒ
10ïŒïŒïŒå®¹éæ¯ïŒãã§å±éãããPGE2ã®åç»ãå
åãã液äœã·ã³ãã¬ãŒã·ãšã³ã«ãŠã³ã¿ãŒã§PGE2
çæéã枬å®ãããã·ã¯ããªãã·ã²ããŒãŒé»å®³äœ
çšã¯ã³ã³ãããŒã«ã®PGE2ã®çæéã«å¯Ÿããæå¶
çããæ±ããããã®çµæãè¡šâïŒã«ç€ºãã
ãè¡šã
(iii) ev vivo MDAç£çæå¶äœçš
äžå€çµ¶é£ãããã©ããïŒãŠã€ã¹ã¿ãŒç³»ãéã
300ã350ïœãäžçŸ€ïŒå¹ïŒã«è¢«æ€ç©è³ªæº¶æ¶²ããžã¡ã
ã«ã¹ã«ããã·ãããã³Cremophorã»ELã®å10ïŒ
ïŒå®¹éïŒå«æ氎溶液ã§ïŒmgïŒmlæ¿åºŠã«èª¿è£œããã€
ãã§ãæ°Žã§ç®çæ¿åºŠã«çšéããããçµå£æäžãã
ïŒæéåŸã«è ¹éšå€§åèããã¯ãšã³é žæ¡è¡ãããïŒ
Ã109ïŒmlã®PRP2mlãïŒïŒãšåæ§ã«åŠçããŠ
MDAç£çæå¶çãæ±ããããã®çµæãè¡šâïŒã«
瀺ãã
300ã350ïœãäžçŸ€ïŒå¹ïŒã«è¢«æ€ç©è³ªæº¶æ¶²ããžã¡ã
ã«ã¹ã«ããã·ãããã³Cremophorã»ELã®å10ïŒ
ïŒå®¹éïŒå«æ氎溶液ã§ïŒmgïŒmlæ¿åºŠã«èª¿è£œããã€
ãã§ãæ°Žã§ç®çæ¿åºŠã«çšéããããçµå£æäžãã
ïŒæéåŸã«è ¹éšå€§åèããã¯ãšã³é žæ¡è¡ãããïŒ
Ã109ïŒmlã®PRP2mlãïŒïŒãšåæ§ã«åŠçããŠ
MDAç£çæå¶çãæ±ããããã®çµæãè¡šâïŒã«
瀺ãã
ãè¡šã
ïŒ æè¡æ äœçšïŒããŠã¹èºæ¢å¡ã¢ãã«ã«å¯Ÿããäœ
çšïŒ G.Diminnoããã³M.J.Silverãã®æ¹æ³ ãJ.Pharmacol.Exp.Therap.ïŒ225(1)57â60
ïŒ1983ïŒãã«æºããŠè¡ã€ããããªãã¡ãããŠã¹ã«ïŒ
ïŒïŒãšåæ§ã«èª¿è£œãã被æ€ç©è³ªæº¶æ¶²ãçµå£æäž
ããïŒæéåŸã«ã³ã©ãŒã²ã³ïŒ150ÎŒïœïŒmlïŒããšã
ããã€ãªã³ïŒ100ÎŒMïŒã®æ··æ¶²0.1mlãéèå æäž
ããæ»äº¡ããã³10å以äžã®éº»çºäŸã®åºçŸäºé²å¹æ
ã調ã¹ãããã®çµæãè¡šâïŒã«ç€ºãã
çšïŒ G.Diminnoããã³M.J.Silverãã®æ¹æ³ ãJ.Pharmacol.Exp.Therap.ïŒ225(1)57â60
ïŒ1983ïŒãã«æºããŠè¡ã€ããããªãã¡ãããŠã¹ã«ïŒ
ïŒïŒãšåæ§ã«èª¿è£œãã被æ€ç©è³ªæº¶æ¶²ãçµå£æäž
ããïŒæéåŸã«ã³ã©ãŒã²ã³ïŒ150ÎŒïœïŒmlïŒããšã
ããã€ãªã³ïŒ100ÎŒMïŒã®æ··æ¶²0.1mlãéèå æäž
ããæ»äº¡ããã³10å以äžã®éº»çºäŸã®åºçŸäºé²å¹æ
ã調ã¹ãããã®çµæãè¡šâïŒã«ç€ºãã
ãè¡šã
ïŒ æ¥æ§æ¯æ§
ããŠã¹ïŒICRç³»ãéãïŒé±ä»€ïŒã«ããã被æ€ç©
質ïŒã®éèå æäžã«ããLD50å€ã¯30mgïŒKg以äž
ã§ãã€ãã 以äžã®çµæãããæ¬çºæååç©ã¯åªããè¡ç®¡æ¡
匵äœçšãããã³ãããµã³åæé µçŽ é»å®³äœçšã«ããš
ããè¡å°æ¿åéæå¶äœçšããã³æè¡æ äœçšãæ
ãããããäœæ¯æ§ã§ããããšã容æã«ç解ã§ã
ãã åŸã€ãŠæ¬çºæååç©ã¯ãè¡ç®¡æ¡åŒµå€ãéå§å€ã
æè¡æ å€ãã«ã«ã·ãŠã æ®æå€ãªã©ãšããŠæçšãªå
åç©ã§ããã æ¬çºæååç©ãå»è¬ãšããŠçšããå Žåãããèª
äœãŸãã¯å»è¬äžèš±å®¹ããåŸã賊圢å€ãæ äœãåžé
å€ãªã©ã®æ·»å å€ãé©å®æ··åããé å€ãã«ãã»ã«
å€ãé¡ç²å€ãç²æ«ãŸãã¯æ³šå°å€ãªã©ã®åœ¢æ ã§çµå£
çãŸãã¯éçµå£çã«æäžã§ãããæäžéã¯çµå£æ
äžã®å Žåãéåžžæ人ïŒæ¥åœã10ã600mgçšåºŠã§ã
ãããïŒåãŸãã¯æ°åã«åããŠæäžããããã幎
什ãäœéããã³çç¶ã«å¿ããŠé©å®éžæãããã 以äžæ¬çºæãããã«è©³çŽ°ã«èª¬æããããã«ãå
èäŸã補é äŸããã³è£œå€äŸãæããããæ¬çºæã¯
ãããã«éå®ããããã®ã§ã¯ãªãã åèäŸ ïŒ (1) ïŒâïŒïŒâã€ãããŸãªã«ïŒããã³é žã»å¡©é žå¡©
3.7ïœãå¡©åããªãã«37mlã«æº¶è§£ãããïŒïŒ®
âãžã¡ãã«ãã«ã ã¢ããïŒæ»Žãå ããŠå ç±éæµ
äžã«ïŒæéåå¿ããããã€ãã§ãæžå§äžã«éå°
ã®å¡©åããªãã«ãçå»ããã°ãïŒâïŒïŒâã€ã
ããŸãªã«ïŒããã³é žã¯ããªãã»å¡©é žå¡©ãæ®çç©
ãšããŠåŸããããããå¡©åã¡ãã¬ã³30mlã«æº¶è§£
ãããã (2) ïŒâãã³ãžã«ã¢ãããšã¿ããŒã«2.34ïœãå¡©å
ã¡ãã¬ã³30mlã«æ·»å ããããã«æ°·å·äžãïŒïŒ¯
âãã¹ïŒããªã¡ãã«ã·ãªã«ïŒã¢ã»ãã¢ãã7.4
mlãå ããŠå®€æž©ã§30åéæªæããããã€ãã§ã
ãã®åå¿æ¶²ã«(1)ã§åŸãããå¡©åã¡ãã¬ã³æº¶æ¶²ã
â10ãïŒâã§æ»ŽäžããåŸã宀枩ã§ïŒæéåå¿ã
ãããæžå§äžã«æº¶åªãçå»ããåŸãããæ®çç©
ãé ¢é žãšãã«80mlããã³æ°Ž50mlã®æ··å溶åªã«æº¶
解ããã2Nâå¡©é žãçšããŠPHïŒã«èª¿æŽããåŸã
30åéæªæãããã€ãã§ãæ°Žå±€ãååãããã
ã«é ¢é žãšãã«100mlãå ãã1Nâæ°Žé žåãããª
ãŠã 氎溶液ãçšããŠPH10ã«èª¿æŽããåŸãææ©å±€
ãååãããææ©å±€ãæ°Ž50mlããã³é£œåé£å¡©æ°Ž
50mlã§é 次æŽæµããç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥
ãããåŸãæžå§äžã«æº¶åªãçå»ãããåŸããã
æ®çç©ãã«ã©ã ã¯ãããã°ã©ãã€ãŒãåå ã·ãª
ã«ã²ã«ïŒ£â200ïŒæº¶åºæº¶åªãã¯ãããã«ã ïŒãš
ã¿ããŒã«æ··å液ïŒå®¹éæ¯ïŒ30ïŒïŒïŒãã§ç²Ÿè£œã
ãã°ãâãã³ãžã«ââïŒïŒâããããã·ãš
ãã«ïŒâïŒâïŒïŒâã€ãããŸãªã«ïŒããã³é žã¢ã
ã2.5ïœïŒåç49ïŒ ïŒãæ²¹ç¶ç©ãšããŠåŸãã IRïŒãã€ã«ã ïŒcm-1ïŒ3380ã2930ã1630 NMRïŒd6âDMSOãå¡©é žå¡©ïŒÎŽå€ïŒ 0.92ã2.05ïŒ12HïŒïœïŒã2.15ã2.79ïŒ2HïŒïœïŒã 3.29ã3.85ïŒ2HïŒïœïŒã3.85ã4.83ïŒ7HïŒïœïŒã 7.05ã8.02ïŒ7HïŒïœïŒã9.42ïŒ1HïŒïœïŒã 9.80ïŒ1HïŒbsïŒ åæ§ã«ããŠïŒâïŒïŒ®âãã³ãžã«ã¢ããïŒâïŒâ
ïŒïŒâããšãã«ïŒãšã¿ããŒã« IRïŒKBrïŒcm-1ïŒ3390 NMRïŒCDCl3ïŒÎŽå€ïŒ 2.92ïŒ2HïŒïœïŒïŒªïŒïŒHzïŒã3.05ïŒ2HïŒbsïŒã 3.80ïŒ2HïŒïœïŒã5.00ïŒ1HïŒïœïŒïŒªïŒïŒHzïŒã 6.80ã7.10ïŒ2HïŒïœïŒã7.10ã7.50ïŒïŒHzïŒïœïŒ ããâãã³ãžã«ââãïŒâããããã·âïŒâ
ïŒïŒâããšãã«ïŒãšãã«ãâïŒâïŒïŒâã€ãããŸãª
ã«ïŒããã³é žã¢ããïŒæ²¹ç¶ïŒãåŸãã IRïŒãã€ã«ã ïŒcm-1ïŒ3350ã2930ã1635 NMRïŒCDCl3ïŒD2ïŒÎŽå€ïŒ 1.0ã2.0ïŒ12HïŒïœïŒã2.33ïŒ2HïŒïœïŒïŒªïŒïŒ
HzïŒã 3.4ã4.0ïŒ4HïŒïœïŒã4.56ïŒ2HïŒABqïŒïŒªïŒ15
HzïŒã 5.32ïŒ1HïŒïœïŒïŒªïŒïŒHzïŒã6.9ã7.7ïŒ11HïŒ
ïœïŒ åèäŸ ïŒ ïŒ®âãã³ãžã«ââïŒïŒâããããã·ãšãã«ïŒâ
ïŒâïŒïŒâã€ãããŸãªã«ïŒããã³é žã¢ãã0.8ïœã
ããã©ããããã©ã³ïŒmlã«æº¶è§£ãããããªãšãã«
ã¢ãã³ãïŒæ»Žå ããããã®æº¶æ¶²ã«ãžã±ãã³0.2ïœ
ãšããã©ããããã©ã³ïŒmlãšããæã溶液ãå ç±
éæµäžã20åãèŠããŠæ»Žäžããå枩床ã§ïŒæéå
å¿ããããã€ãã§ãæžå§äžã«æº¶åªãçå»ããåŸã
ããæ®çç©ãã¢ã©ã ã¯ãããã°ã©ãã€ãŒãåå ã·
ãªã«ã²ã«ïŒ£â200ïŒæº¶åºæº¶åªãã¯ãããã«ã ïŒãš
ã¿ããŒã«æ··å液ïŒå®¹éæ¯ïŒ30ïŒïŒïŒãã§ç²Ÿè£œãã
ã°ãâïŒïŒâã¢ã»ãã¢ã»ãã«ãªãã·ãšãã«ïŒâ
âãã³ãžã«âïŒâïŒïŒâã€ãããŸãªã«ïŒããã³é ž
ã¢ãã0.8ïœïŒåç80.8ïŒ ïŒãæ²¹ç¶ç©ãšããŠåŸãã IRïŒãã€ã«ã ïŒcm-1ïŒ2930ã1745ã1720ã1640 NMRïŒCDCl3ïŒÎŽå€ïŒ 0.92ã2.07ïŒ12HïŒïœïŒã2.27(s) 2.07ã2.62(m) 5Hã 3.45ïŒ2HïŒïœïŒã4.68ïŒ2HïŒïœïŒã3.50ã4.50 ïŒ6HïŒïœïŒã6.77ã7.62ïŒ8HïŒïœïŒ åæ§ã«ããŠãã€ãã®ååç©ãåŸãã âãïŒâã¢ã»ãã¢ã»ãã«ãªãã·âïŒâïŒïŒâã
ãšãã«ïŒãšãã«ãââãã³ãžã«âïŒâïŒïŒâã€ã
ããŸãªã«ïŒããã³é žã¢ããïŒæ²¹ç¶ïŒ IRïŒãã€ã«ã ïŒcm-1ïŒ2930ã1745ã1720ã1640 NMRïŒCDCl3ïŒÎŽå€ïŒ 1.0ã2.0ïŒ12HïŒïœïŒã2.1ã2.5ïŒ5HïŒïœïŒã 3.43ïŒ2HïŒïœïŒã3.6ã4.1ïŒ4HïŒïœïŒã 4.56ïŒ2HïŒABqïŒïŒªïŒ15HzïŒã6.2ã6.7ïŒ1HïŒ
ïœïŒã 6.8ã7.6ïŒ11HïŒïœïŒ 補é äŸ ïŒ ïŒ®âïŒïŒâã¢ã»ãã¢ã»ãã«ãªãã·ãšãã«ïŒââ
ãã³ãžã«âïŒâïŒïŒâã€ãããŸãªã«ïŒããã³é žã¢
ãã0.3ïœãïŒâã¢ããã¯ããã³é žïŒâïŒïŒ®âãã³
ãžã«ââã¡ãã«ã¢ããïŒãšãã«ãšã¹ãã«0.17ïœ
ããã³ïŒâããããã³ãºã¢ã«ããã0.1ïœããšã¿
ããŒã«10mlã«æº¶è§£ãããå ç±éæµäžã«ïŒæéåå¿
ããããã€ãã§ã溶åªãæžå§äžã«çå»ããåŸãã
ãæ®çç©ãã«ã©ã ã¯ãããã°ã©ãã€ãŒãåå ã·ãª
ã«ã²ã«ïŒ£â200ïŒæº¶åºæº¶åªãã¯ãããã«ã ïŒãšã¿
ããŒã«æ··å液ïŒå®¹éæ¯ïŒ30ïŒïŒïŒãã§ç²Ÿè£œããã°ã
é»è²æ²¹ç¶ã®ïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâããã
ããšãã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒ
âãžã«ã«ãã³é žâïŒâãïŒâãâãã³ãžã«ââ
ãïŒâïŒïŒâã€ãããŸãªã«ïŒãããã€ã«ãã¢ããã
ãšãã«ããšã¹ãã«âïŒâãïŒâïŒïŒ®âãã³ãžã«â
âã¡ãã«ã¢ããïŒãšãã«ããšã¹ãã«0.29ïœïŒåç
52.2ïŒ ïŒãåŸãã IRïŒãã€ã«ã ïŒcm-1ïŒ 2925ã1650ã1630ã1520ã1350 NMRïŒCDCl3ïŒÎŽå€ïŒ 1.00ã1.96ïŒ12HïŒïœïŒã2.21(s) 2.38(s) 2.03ã2.50(m)11H 3.30ã4.75ïŒ14HïŒïœïŒã5.20ïŒ1HïŒïœïŒã 6.88ã8.65ïŒ18HïŒïœïŒ åæ§ã«ããŠãè¡šâïŒã®ååç©ãåŸãã
質ïŒã®éèå æäžã«ããLD50å€ã¯30mgïŒKg以äž
ã§ãã€ãã 以äžã®çµæãããæ¬çºæååç©ã¯åªããè¡ç®¡æ¡
匵äœçšãããã³ãããµã³åæé µçŽ é»å®³äœçšã«ããš
ããè¡å°æ¿åéæå¶äœçšããã³æè¡æ äœçšãæ
ãããããäœæ¯æ§ã§ããããšã容æã«ç解ã§ã
ãã åŸã€ãŠæ¬çºæååç©ã¯ãè¡ç®¡æ¡åŒµå€ãéå§å€ã
æè¡æ å€ãã«ã«ã·ãŠã æ®æå€ãªã©ãšããŠæçšãªå
åç©ã§ããã æ¬çºæååç©ãå»è¬ãšããŠçšããå Žåãããèª
äœãŸãã¯å»è¬äžèš±å®¹ããåŸã賊圢å€ãæ äœãåžé
å€ãªã©ã®æ·»å å€ãé©å®æ··åããé å€ãã«ãã»ã«
å€ãé¡ç²å€ãç²æ«ãŸãã¯æ³šå°å€ãªã©ã®åœ¢æ ã§çµå£
çãŸãã¯éçµå£çã«æäžã§ãããæäžéã¯çµå£æ
äžã®å Žåãéåžžæ人ïŒæ¥åœã10ã600mgçšåºŠã§ã
ãããïŒåãŸãã¯æ°åã«åããŠæäžããããã幎
什ãäœéããã³çç¶ã«å¿ããŠé©å®éžæãããã 以äžæ¬çºæãããã«è©³çŽ°ã«èª¬æããããã«ãå
èäŸã補é äŸããã³è£œå€äŸãæããããæ¬çºæã¯
ãããã«éå®ããããã®ã§ã¯ãªãã åèäŸ ïŒ (1) ïŒâïŒïŒâã€ãããŸãªã«ïŒããã³é žã»å¡©é žå¡©
3.7ïœãå¡©åããªãã«37mlã«æº¶è§£ãããïŒïŒ®
âãžã¡ãã«ãã«ã ã¢ããïŒæ»Žãå ããŠå ç±éæµ
äžã«ïŒæéåå¿ããããã€ãã§ãæžå§äžã«éå°
ã®å¡©åããªãã«ãçå»ããã°ãïŒâïŒïŒâã€ã
ããŸãªã«ïŒããã³é žã¯ããªãã»å¡©é žå¡©ãæ®çç©
ãšããŠåŸããããããå¡©åã¡ãã¬ã³30mlã«æº¶è§£
ãããã (2) ïŒâãã³ãžã«ã¢ãããšã¿ããŒã«2.34ïœãå¡©å
ã¡ãã¬ã³30mlã«æ·»å ããããã«æ°·å·äžãïŒïŒ¯
âãã¹ïŒããªã¡ãã«ã·ãªã«ïŒã¢ã»ãã¢ãã7.4
mlãå ããŠå®€æž©ã§30åéæªæããããã€ãã§ã
ãã®åå¿æ¶²ã«(1)ã§åŸãããå¡©åã¡ãã¬ã³æº¶æ¶²ã
â10ãïŒâã§æ»ŽäžããåŸã宀枩ã§ïŒæéåå¿ã
ãããæžå§äžã«æº¶åªãçå»ããåŸãããæ®çç©
ãé ¢é žãšãã«80mlããã³æ°Ž50mlã®æ··å溶åªã«æº¶
解ããã2Nâå¡©é žãçšããŠPHïŒã«èª¿æŽããåŸã
30åéæªæãããã€ãã§ãæ°Žå±€ãååãããã
ã«é ¢é žãšãã«100mlãå ãã1Nâæ°Žé žåãããª
ãŠã 氎溶液ãçšããŠPH10ã«èª¿æŽããåŸãææ©å±€
ãååãããææ©å±€ãæ°Ž50mlããã³é£œåé£å¡©æ°Ž
50mlã§é 次æŽæµããç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥
ãããåŸãæžå§äžã«æº¶åªãçå»ãããåŸããã
æ®çç©ãã«ã©ã ã¯ãããã°ã©ãã€ãŒãåå ã·ãª
ã«ã²ã«ïŒ£â200ïŒæº¶åºæº¶åªãã¯ãããã«ã ïŒãš
ã¿ããŒã«æ··å液ïŒå®¹éæ¯ïŒ30ïŒïŒïŒãã§ç²Ÿè£œã
ãã°ãâãã³ãžã«ââïŒïŒâããããã·ãš
ãã«ïŒâïŒâïŒïŒâã€ãããŸãªã«ïŒããã³é žã¢ã
ã2.5ïœïŒåç49ïŒ ïŒãæ²¹ç¶ç©ãšããŠåŸãã IRïŒãã€ã«ã ïŒcm-1ïŒ3380ã2930ã1630 NMRïŒd6âDMSOãå¡©é žå¡©ïŒÎŽå€ïŒ 0.92ã2.05ïŒ12HïŒïœïŒã2.15ã2.79ïŒ2HïŒïœïŒã 3.29ã3.85ïŒ2HïŒïœïŒã3.85ã4.83ïŒ7HïŒïœïŒã 7.05ã8.02ïŒ7HïŒïœïŒã9.42ïŒ1HïŒïœïŒã 9.80ïŒ1HïŒbsïŒ åæ§ã«ããŠïŒâïŒïŒ®âãã³ãžã«ã¢ããïŒâïŒâ
ïŒïŒâããšãã«ïŒãšã¿ããŒã« IRïŒKBrïŒcm-1ïŒ3390 NMRïŒCDCl3ïŒÎŽå€ïŒ 2.92ïŒ2HïŒïœïŒïŒªïŒïŒHzïŒã3.05ïŒ2HïŒbsïŒã 3.80ïŒ2HïŒïœïŒã5.00ïŒ1HïŒïœïŒïŒªïŒïŒHzïŒã 6.80ã7.10ïŒ2HïŒïœïŒã7.10ã7.50ïŒïŒHzïŒïœïŒ ããâãã³ãžã«ââãïŒâããããã·âïŒâ
ïŒïŒâããšãã«ïŒãšãã«ãâïŒâïŒïŒâã€ãããŸãª
ã«ïŒããã³é žã¢ããïŒæ²¹ç¶ïŒãåŸãã IRïŒãã€ã«ã ïŒcm-1ïŒ3350ã2930ã1635 NMRïŒCDCl3ïŒD2ïŒÎŽå€ïŒ 1.0ã2.0ïŒ12HïŒïœïŒã2.33ïŒ2HïŒïœïŒïŒªïŒïŒ
HzïŒã 3.4ã4.0ïŒ4HïŒïœïŒã4.56ïŒ2HïŒABqïŒïŒªïŒ15
HzïŒã 5.32ïŒ1HïŒïœïŒïŒªïŒïŒHzïŒã6.9ã7.7ïŒ11HïŒ
ïœïŒ åèäŸ ïŒ ïŒ®âãã³ãžã«ââïŒïŒâããããã·ãšãã«ïŒâ
ïŒâïŒïŒâã€ãããŸãªã«ïŒããã³é žã¢ãã0.8ïœã
ããã©ããããã©ã³ïŒmlã«æº¶è§£ãããããªãšãã«
ã¢ãã³ãïŒæ»Žå ããããã®æº¶æ¶²ã«ãžã±ãã³0.2ïœ
ãšããã©ããããã©ã³ïŒmlãšããæã溶液ãå ç±
éæµäžã20åãèŠããŠæ»Žäžããå枩床ã§ïŒæéå
å¿ããããã€ãã§ãæžå§äžã«æº¶åªãçå»ããåŸã
ããæ®çç©ãã¢ã©ã ã¯ãããã°ã©ãã€ãŒãåå ã·
ãªã«ã²ã«ïŒ£â200ïŒæº¶åºæº¶åªãã¯ãããã«ã ïŒãš
ã¿ããŒã«æ··å液ïŒå®¹éæ¯ïŒ30ïŒïŒïŒãã§ç²Ÿè£œãã
ã°ãâïŒïŒâã¢ã»ãã¢ã»ãã«ãªãã·ãšãã«ïŒâ
âãã³ãžã«âïŒâïŒïŒâã€ãããŸãªã«ïŒããã³é ž
ã¢ãã0.8ïœïŒåç80.8ïŒ ïŒãæ²¹ç¶ç©ãšããŠåŸãã IRïŒãã€ã«ã ïŒcm-1ïŒ2930ã1745ã1720ã1640 NMRïŒCDCl3ïŒÎŽå€ïŒ 0.92ã2.07ïŒ12HïŒïœïŒã2.27(s) 2.07ã2.62(m) 5Hã 3.45ïŒ2HïŒïœïŒã4.68ïŒ2HïŒïœïŒã3.50ã4.50 ïŒ6HïŒïœïŒã6.77ã7.62ïŒ8HïŒïœïŒ åæ§ã«ããŠãã€ãã®ååç©ãåŸãã âãïŒâã¢ã»ãã¢ã»ãã«ãªãã·âïŒâïŒïŒâã
ãšãã«ïŒãšãã«ãââãã³ãžã«âïŒâïŒïŒâã€ã
ããŸãªã«ïŒããã³é žã¢ããïŒæ²¹ç¶ïŒ IRïŒãã€ã«ã ïŒcm-1ïŒ2930ã1745ã1720ã1640 NMRïŒCDCl3ïŒÎŽå€ïŒ 1.0ã2.0ïŒ12HïŒïœïŒã2.1ã2.5ïŒ5HïŒïœïŒã 3.43ïŒ2HïŒïœïŒã3.6ã4.1ïŒ4HïŒïœïŒã 4.56ïŒ2HïŒABqïŒïŒªïŒ15HzïŒã6.2ã6.7ïŒ1HïŒ
ïœïŒã 6.8ã7.6ïŒ11HïŒïœïŒ 補é äŸ ïŒ ïŒ®âïŒïŒâã¢ã»ãã¢ã»ãã«ãªãã·ãšãã«ïŒââ
ãã³ãžã«âïŒâïŒïŒâã€ãããŸãªã«ïŒããã³é žã¢
ãã0.3ïœãïŒâã¢ããã¯ããã³é žïŒâïŒïŒ®âãã³
ãžã«ââã¡ãã«ã¢ããïŒãšãã«ãšã¹ãã«0.17ïœ
ããã³ïŒâããããã³ãºã¢ã«ããã0.1ïœããšã¿
ããŒã«10mlã«æº¶è§£ãããå ç±éæµäžã«ïŒæéåå¿
ããããã€ãã§ã溶åªãæžå§äžã«çå»ããåŸãã
ãæ®çç©ãã«ã©ã ã¯ãããã°ã©ãã€ãŒãåå ã·ãª
ã«ã²ã«ïŒ£â200ïŒæº¶åºæº¶åªãã¯ãããã«ã ïŒãšã¿
ããŒã«æ··å液ïŒå®¹éæ¯ïŒ30ïŒïŒïŒãã§ç²Ÿè£œããã°ã
é»è²æ²¹ç¶ã®ïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâããã
ããšãã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒ
âãžã«ã«ãã³é žâïŒâãïŒâãâãã³ãžã«ââ
ãïŒâïŒïŒâã€ãããŸãªã«ïŒãããã€ã«ãã¢ããã
ãšãã«ããšã¹ãã«âïŒâãïŒâïŒïŒ®âãã³ãžã«â
âã¡ãã«ã¢ããïŒãšãã«ããšã¹ãã«0.29ïœïŒåç
52.2ïŒ ïŒãåŸãã IRïŒãã€ã«ã ïŒcm-1ïŒ 2925ã1650ã1630ã1520ã1350 NMRïŒCDCl3ïŒÎŽå€ïŒ 1.00ã1.96ïŒ12HïŒïœïŒã2.21(s) 2.38(s) 2.03ã2.50(m)11H 3.30ã4.75ïŒ14HïŒïœïŒã5.20ïŒ1HïŒïœïŒã 6.88ã8.65ïŒ18HïŒïœïŒ åæ§ã«ããŠãè¡šâïŒã®ååç©ãåŸãã
ãè¡šã
補é äŸ ïŒ
ïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒ
âïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãžã«ã«ã
ã³é žâïŒâãïŒâïŒïŒ®âãã³ãžã«ã¢ããïŒãšãã«ã
ãšã¹ãã«âïŒâãšãã«ãšã¹ãã«ãé»è²æ²¹ç¶ãIR
ïŒãã€ã«ã ïŒcm-1ïŒ3340ã2970ã1685ã1525ã
1345ã1.7ïœããã³ããªãšãã«ã¢ãã³ïŒmlãå¡©å
ã¡ãã¬ã³10mlã«æº¶è§£ãããããã®æº¶æ¶²ã«ãåèäŸ
ïŒâ(1)ãšåæ§ã«ããŠãïŒâïŒïŒâã€ãããŸãªã«ïŒ
ããã³é žã»å¡©é žå¡©0.84ïœããåŸãããïŒâïŒïŒâ
ã€ãããŸãªã«ïŒããã³é žã¯ããªãã®å¡©é žå¡©ã®å¡©å
ã¡ãã¬ã³æº¶æ¶²ïŒmlãâ20ãâ10âã§æ»Žäžãã宀枩
ã§30åéåå¿ããããã€ãã§ãåå¿æ¶²ã«å¡©åã¡ã
ã¬ã³50mlããã³æ°Ž25mlãå ãã1Nâæ°Žé žåãã
ãªãŠã 氎溶液ãçšããŠPHïŒã«èª¿æŽãããã€ãã§ã
ææ©å±€ãååããæ°Ž25mlããã³é£œåé£å¡©æ°Ž25mlã§
é 次æŽæµããåŸãç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥ã
ããæžå§äžã«æº¶åªãçå»ãããåŸãããæ®çç©ã
ã«ã©ã ã¯ãããã°ã©ãã€ãŒãåå ã·ãªã«ã²ã«ïŒ£â
200ïŒæº¶åºæº¶åªãã¯ãããã«ã ïŒãšã¿ããŒã«æ··å
液ïŒå®¹éæ¯ïŒ30ïŒïŒïŒãã§ç²Ÿè£œããã°é»è²æ²¹ç¶ã®
ïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâ
ïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãžã«ã«ãã³
é žâïŒâãïŒâãâãã³ãžã«ââãïŒâïŒïŒâã€
ãããŸãªã«ïŒãããã€ã«ãã¢ããããšãã«ããšã¹
ãã«âïŒâãšãã«ãšã¹ãã«0.6ïœïŒåç27.3ïŒ ïŒ
ãåŸãã IRïŒãã€ã«ã ïŒcm-1ïŒ2930ã1685ã1625ã
1520ã1350 NMRïŒCDCl3ïŒÎŽå€ïŒ 0.90ã2.00ïŒ15HãïœïŒã2.38(s) 2.00ã2.55(m) 8Hã 3.30ã4.75ïŒ10HïŒïœïŒã5.17ïŒ1HïŒïœïŒã 6.90ã8.40ïŒ13HïŒïœïŒ åæ§ã«ããŠè¡šâïŒã®ååç©ãåŸãã
âïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãžã«ã«ã
ã³é žâïŒâãïŒâïŒïŒ®âãã³ãžã«ã¢ããïŒãšãã«ã
ãšã¹ãã«âïŒâãšãã«ãšã¹ãã«ãé»è²æ²¹ç¶ãIR
ïŒãã€ã«ã ïŒcm-1ïŒ3340ã2970ã1685ã1525ã
1345ã1.7ïœããã³ããªãšãã«ã¢ãã³ïŒmlãå¡©å
ã¡ãã¬ã³10mlã«æº¶è§£ãããããã®æº¶æ¶²ã«ãåèäŸ
ïŒâ(1)ãšåæ§ã«ããŠãïŒâïŒïŒâã€ãããŸãªã«ïŒ
ããã³é žã»å¡©é žå¡©0.84ïœããåŸãããïŒâïŒïŒâ
ã€ãããŸãªã«ïŒããã³é žã¯ããªãã®å¡©é žå¡©ã®å¡©å
ã¡ãã¬ã³æº¶æ¶²ïŒmlãâ20ãâ10âã§æ»Žäžãã宀枩
ã§30åéåå¿ããããã€ãã§ãåå¿æ¶²ã«å¡©åã¡ã
ã¬ã³50mlããã³æ°Ž25mlãå ãã1Nâæ°Žé žåãã
ãªãŠã 氎溶液ãçšããŠPHïŒã«èª¿æŽãããã€ãã§ã
ææ©å±€ãååããæ°Ž25mlããã³é£œåé£å¡©æ°Ž25mlã§
é 次æŽæµããåŸãç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥ã
ããæžå§äžã«æº¶åªãçå»ãããåŸãããæ®çç©ã
ã«ã©ã ã¯ãããã°ã©ãã€ãŒãåå ã·ãªã«ã²ã«ïŒ£â
200ïŒæº¶åºæº¶åªãã¯ãããã«ã ïŒãšã¿ããŒã«æ··å
液ïŒå®¹éæ¯ïŒ30ïŒïŒïŒãã§ç²Ÿè£œããã°é»è²æ²¹ç¶ã®
ïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâ
ïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãžã«ã«ãã³
é žâïŒâãïŒâãâãã³ãžã«ââãïŒâïŒïŒâã€
ãããŸãªã«ïŒãããã€ã«ãã¢ããããšãã«ããšã¹
ãã«âïŒâãšãã«ãšã¹ãã«0.6ïœïŒåç27.3ïŒ ïŒ
ãåŸãã IRïŒãã€ã«ã ïŒcm-1ïŒ2930ã1685ã1625ã
1520ã1350 NMRïŒCDCl3ïŒÎŽå€ïŒ 0.90ã2.00ïŒ15HãïœïŒã2.38(s) 2.00ã2.55(m) 8Hã 3.30ã4.75ïŒ10HïŒïœïŒã5.17ïŒ1HïŒïœïŒã 6.90ã8.40ïŒ13HïŒïœïŒ åæ§ã«ããŠè¡šâïŒã®ååç©ãåŸãã
ãè¡šã
補é äŸ ïŒ
(1) ïŒâïŒïŒâã€ãããŸãªã«ïŒããã¿ã³é
žã»å¡©é
ž
å¡©0.3ïœãå¡©åããªãã«ïŒmlã«æº¶è§£ãããïŒ
âãžã¡ãã«ãã«ã ã¢ããïŒæ»Žãå ããŠå ç±é
æµäžã«ïŒæéåå¿ããããã€ãã§ãæžå§äžã«é
å°ã®å¡©åããªãã«ãçå»ããã°ãïŒâïŒïŒâã€
ãããŸãªã«ïŒããã¿ã³é žã¯ããªãã®å¡©é žå¡©ãæ®
çç©ãšããŠåŸããããããå¡©åã¡ãã¬ã³ïŒmlã«
溶解ãããã (2) ïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããšã
ã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãž
ã«ã«ãã³é žâïŒâãïŒâïŒïŒ®âãã³ãžã«ã¢ããïŒ
ãšãã«ããšã¹ãã«âïŒâãšãã«ãšã¹ãã«0.56ïœ
ãå¡©åãšãã¬ã³ïŒmlã«æº¶è§£ãããããã«æ°·å·
äžãïŒïŒ¯âãã¹ïŒããªã¡ãã«ã·ãªã«ïŒã¢ã»ã
ã¢ãã0.6mlãå ããŠå®€æž©ã§30åéæªæãããã
ã€ãã§ããã®åå¿æ¶²ã«(1)ã§åŸãããå¡©åã¡ãã¬
ã³æº¶æ¶²ãâ10ãâïŒâã§æ»ŽäžããåŸã宀枩ã§ïŒ
æéåå¿ããããããã«ãåå¿æ¶²ã«å¡©åã¡ãã¬
ã³10mlããã³æ°Ž10mlãå ããŠã宀枩ã§30åéæª
æããããã€ãã§ãããã1Nâæ°Žé žåãããª
ãŠã 氎溶液ãçšããŠPHïŒã«èª¿æŽããææ©å±€ãå
åããåŸãæ°Ž10mlããã³é£œåé£å¡©æ°Ž10mlã§é 次
æŽæµããç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥ãããæžå§
äžã«æº¶åªãçå»ããåŸãããæ®çç©ãã«ã©ã ã¯
ãããã°ã©ãã€ãŒãåå ã·ãªã«ã²ã«ïŒ£â200ïŒ
溶åºæº¶åªãã¯ãããã«ã ïŒãšã¿ããŒã«æ··å液
ïŒå®¹éæ¯ïŒ30ïŒïŒïŒãã§ç²Ÿè£œããã°ãé»è²æ²¹ç¶ã®
ïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒ
âïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãžã«ã«
ãã³é žâïŒâãïŒâãâãã³ãžã«ââãïŒâ
ïŒïŒâã€ãããŸãªã«ïŒããã¿ãã€ã«ãã¢ããã
ãšãã«ããšã¹ãã«âïŒâãšãã«ãšã¹ãã«0.3ïœ
ïŒåç35.4ïŒ ïŒãåŸãã IRïŒãã€ã«ã ïŒcm-1ïŒ2920ã1690ã1630ã
1520ã1340 NMRïŒCDCl3ïŒÎŽå€ïŒ 0.90ã2.00ïŒ11HïŒïœïŒã2.40(s) 2.10ã2.60(m) 8Hã 3.25ã4.88ïŒ10HïŒïœïŒã5.20ïŒ1HïŒïœïŒã 6.60ã8.82ïŒ13HïŒïœïŒ åæ§ã«ããŠã€ãã®ååç©ãåŸãã ïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒ
âïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãžã«ã«ã
ã³é žâïŒâãïŒâãâãïŒâïŒïŒâã€ãããŸãªã«ïŒ
ãã¿ãã€ã«ãââã¡ãã«ã¢ããããšãã«ããšã¹
ãã«âïŒâãšãã«ãšã¹ãã«ïŒé»è²æ²¹ç¶ïŒ IRïŒãã€ã«ã ïŒcm-1ïŒ2930ã1690ã1625ã
1520ã1345 NMRïŒCDCl3ïŒÎŽå€ïŒ 1.24ïŒ3HïŒïœïŒïŒªïŒïŒHzïŒã2.38(s) 1.90ã2.60(m) 10Hã 2.90ïŒ3HïŒïœïŒã3.63ïŒ2HïŒïœïŒã 3.90ã4.55ïŒ6HïŒïœïŒã5.15ïŒ1HïŒïœïŒã 6.85ã8.35ïŒ8HïŒïœïŒ ãŸãåæ§ã«ããŠïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâ
ãããããšãã«ïŒâïŒïŒïŒâãžãããããªãžã³â
ïŒïŒïŒâãžã«ã«ãã³é žâïŒâãïŒâãâïŒïŒâã¯
ãããã³ãžã«ïŒã¢ããããšãã«ããšã¹ãã«âïŒâ
ãšãã«ãšã¹ãã«ãé»è²æ²¹ç¶ãIRïŒãã€ã«ã ïŒcm-
ïŒïŒ3340ã3020ã1685ã1615ã1525ã1350ããã
ïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâ
ïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãžã«ã«ãã³
é žâïŒâãïŒâãâïŒïŒâã¯ãããã³ãžã«ïŒââ
ãïŒâïŒïŒâã€ãããŸãªã«ïŒãããã€ã«ãã¢ããã
ãšãã«ããšã¹ãã«âïŒâãšãã«ãšã¹ãã«ãåŸãã é»è²æ²¹ç¶ IRïŒãã€ã«ã ïŒcm-1ïŒ2930ã1690ã1625ã
1520ã1350 NMRïŒCDCl3ïŒÎŽå€ïŒ 0.90ã2.00ïŒ15HïŒïœïŒã2.38(s) 2.08ã2.68(m) 8Hã 3.20ã4.70ïŒ10HïŒïœïŒã5.13ïŒ1HïŒïœïŒã 6.68ã8.30ïŒ12HïŒïœïŒ 補é äŸ ïŒ (1) (E)âïŒâã¡ãã«âïŒâãïŒâïŒïŒâããªãžã«ã¡
ãã«ïŒããšãã«ãã¢ã¯ãªã«é žã»å¡©é žå¡©0.2ïœã
å¡©åããªãã«ïŒmlã«æº¶è§£ãããïŒïŒ®âãžã¡ã
ã«ãã«ã ã¢ããïŒæ»Žãå ããŠå ç±éæµäžã«ïŒæ
éåå¿ããããã€ãã§ãæžå§äžã«éå°ã®å¡©åã
ãªãã«ãçå»ããã°ã(E)âïŒâã¡ãã«âïŒâ
ãïŒâïŒïŒâããªãžã«ã¡ãã«ïŒããšãã«ãã¢ã¯ãª
ã«é žã¯ããªãã®å¡©é žå¡©ãæ®çç©ãšããŠåŸããã
ãããå¡©åã¡ãã¬ã³ïŒmlã«æº¶è§£ãããã (2) ïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããšã
ã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãž
ã«ã«ãã³é žâïŒâãšãã«ãšã¹ãã«âïŒâãïŒâ
ïŒïŒ®âã¡ãã«ã¢ããïŒãšãã«ããšã¹ãã«0.25ïœ
ãå¡©åã¡ãã¬ã³ïŒmlã«æº¶è§£ãããããã«æ°·å·
äžãïŒïŒ¯âãã¹ïŒããªã¡ãã«ã·ãªã«ïŒã¢ã»ã
ã¢ãã0.17mlãå ããŠå®€æž©ã§30åéæªæãã
ãã ã€ãã§ããã®åå¿æ¶²ã«ã(1)ã§åŸãããå¡©åã¡ã
ã¬ã³æº¶æ¶²ãâ10ãâïŒâã§æ»ŽäžããåŸã宀枩ã§ïŒ
æéåå¿ããããæžå§äžã«æº¶åªãçå»ããåŸãã
ãæ®çç©ã«é ¢é žãšãã«10mlããã³æ°Ž10mlãå ãã
1Nâæ°Žé žåãããªãŠã 氎溶液ãçšããŠPHïŒã«èª¿
æŽããææ©å±€ãååããããã®æº¶æ¶²ãæ°Ž10mlãã
ã³é£œåé£å¡©æ°Ž10mlã§é 次æŽæµããåŸãæžå§äžã«æº¶
åªãçå»ããåŸãããæ®çç©ãã«ã©ã ã¯ãããã°
ã©ãã€ãŒãåå ã·ãªã«ã²ã«ïŒ£â200ïŒæº¶åºæº¶åªã
ãã³ãŒã³ïŒé ¢é žãšãã«æ··å液ïŒå®¹éæ¯ïŒïŒïŒïŒã
ã§ç²Ÿè£œããã°ãé»è²ç²æ«ã®ïŒïŒïŒâãžã¡ãã«âïŒ
âïŒïŒâãããããšãã«ïŒâïŒïŒïŒâãžãããããª
ãžã³âïŒïŒïŒâãžã«ã«ãã³é žâïŒâãšãã«ãšã¹ã
ã«âïŒâãïŒâãâ(E)âãïŒâãïŒâïŒïŒâããªãž
ã«ã¡ãã«ïŒããšãã«ãã¡ã¿ã¯ãªãã€ã«ãââã¡
ãã«ã¢ããããšãã«ããšã¹ãã«0.17ïœïŒåç43.5
ïŒ ïŒãåŸãã IRïŒKBrïŒcm-1ïŒ2940ã1685ã1610ã1520ã
1345 NMRïŒCDCl3ïŒÎŽå€ïŒ 1.18ïŒ3HïŒïœïŒïŒªïŒïŒHzïŒã2.05ïŒ3HïŒïœïŒã 2.36ïŒ6HïŒïœïŒã3.01ïŒ3HïŒïœïŒã3.37ã4.60 ïŒ8HïŒïœïŒã5.15ïŒ1HïŒïœïŒã6.46ïŒ1HïŒbsïŒã 6.83ã8.80ïŒ13HïŒïœïŒ 補å€äŸ ïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒ
âïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãžã«ã«ã
ã³é žâïŒâãïŒâãâãã³ãžã«ââãïŒâïŒïŒâ
ã€ãããŸãªã«ïŒãããã€ã«ãã¢ããããšãã«ããš
ã¹ãã«âïŒâãšãã«ãšã¹ãã«2.5mgãå«æããé
å€ããäžèšæ·»å å€ãçšããŠãèªäœå ¬ç¥ã®æ¹æ³ã§èª¿
補ããã 10000é ã«ã€ããŠïŒ äžèšååç© 250ïœ ã»ã«ããŒã¹ 700ïœ ã©ã¯ããŒã¹ 780ïœ ããŠã¢ãã³ã·æŸ±ç² 700ïœ ã¹ãã¢ãªã³é žãã°ãã·ãŠã 20ïœ æ°Ž é©éã
å¡©0.3ïœãå¡©åããªãã«ïŒmlã«æº¶è§£ãããïŒ
âãžã¡ãã«ãã«ã ã¢ããïŒæ»Žãå ããŠå ç±é
æµäžã«ïŒæéåå¿ããããã€ãã§ãæžå§äžã«é
å°ã®å¡©åããªãã«ãçå»ããã°ãïŒâïŒïŒâã€
ãããŸãªã«ïŒããã¿ã³é žã¯ããªãã®å¡©é žå¡©ãæ®
çç©ãšããŠåŸããããããå¡©åã¡ãã¬ã³ïŒmlã«
溶解ãããã (2) ïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããšã
ã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãž
ã«ã«ãã³é žâïŒâãïŒâïŒïŒ®âãã³ãžã«ã¢ããïŒ
ãšãã«ããšã¹ãã«âïŒâãšãã«ãšã¹ãã«0.56ïœ
ãå¡©åãšãã¬ã³ïŒmlã«æº¶è§£ãããããã«æ°·å·
äžãïŒïŒ¯âãã¹ïŒããªã¡ãã«ã·ãªã«ïŒã¢ã»ã
ã¢ãã0.6mlãå ããŠå®€æž©ã§30åéæªæãããã
ã€ãã§ããã®åå¿æ¶²ã«(1)ã§åŸãããå¡©åã¡ãã¬
ã³æº¶æ¶²ãâ10ãâïŒâã§æ»ŽäžããåŸã宀枩ã§ïŒ
æéåå¿ããããããã«ãåå¿æ¶²ã«å¡©åã¡ãã¬
ã³10mlããã³æ°Ž10mlãå ããŠã宀枩ã§30åéæª
æããããã€ãã§ãããã1Nâæ°Žé žåãããª
ãŠã 氎溶液ãçšããŠPHïŒã«èª¿æŽããææ©å±€ãå
åããåŸãæ°Ž10mlããã³é£œåé£å¡©æ°Ž10mlã§é 次
æŽæµããç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥ãããæžå§
äžã«æº¶åªãçå»ããåŸãããæ®çç©ãã«ã©ã ã¯
ãããã°ã©ãã€ãŒãåå ã·ãªã«ã²ã«ïŒ£â200ïŒ
溶åºæº¶åªãã¯ãããã«ã ïŒãšã¿ããŒã«æ··å液
ïŒå®¹éæ¯ïŒ30ïŒïŒïŒãã§ç²Ÿè£œããã°ãé»è²æ²¹ç¶ã®
ïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒ
âïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãžã«ã«
ãã³é žâïŒâãïŒâãâãã³ãžã«ââãïŒâ
ïŒïŒâã€ãããŸãªã«ïŒããã¿ãã€ã«ãã¢ããã
ãšãã«ããšã¹ãã«âïŒâãšãã«ãšã¹ãã«0.3ïœ
ïŒåç35.4ïŒ ïŒãåŸãã IRïŒãã€ã«ã ïŒcm-1ïŒ2920ã1690ã1630ã
1520ã1340 NMRïŒCDCl3ïŒÎŽå€ïŒ 0.90ã2.00ïŒ11HïŒïœïŒã2.40(s) 2.10ã2.60(m) 8Hã 3.25ã4.88ïŒ10HïŒïœïŒã5.20ïŒ1HïŒïœïŒã 6.60ã8.82ïŒ13HïŒïœïŒ åæ§ã«ããŠã€ãã®ååç©ãåŸãã ïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒ
âïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãžã«ã«ã
ã³é žâïŒâãïŒâãâãïŒâïŒïŒâã€ãããŸãªã«ïŒ
ãã¿ãã€ã«ãââã¡ãã«ã¢ããããšãã«ããšã¹
ãã«âïŒâãšãã«ãšã¹ãã«ïŒé»è²æ²¹ç¶ïŒ IRïŒãã€ã«ã ïŒcm-1ïŒ2930ã1690ã1625ã
1520ã1345 NMRïŒCDCl3ïŒÎŽå€ïŒ 1.24ïŒ3HïŒïœïŒïŒªïŒïŒHzïŒã2.38(s) 1.90ã2.60(m) 10Hã 2.90ïŒ3HïŒïœïŒã3.63ïŒ2HïŒïœïŒã 3.90ã4.55ïŒ6HïŒïœïŒã5.15ïŒ1HïŒïœïŒã 6.85ã8.35ïŒ8HïŒïœïŒ ãŸãåæ§ã«ããŠïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâ
ãããããšãã«ïŒâïŒïŒïŒâãžãããããªãžã³â
ïŒïŒïŒâãžã«ã«ãã³é žâïŒâãïŒâãâïŒïŒâã¯
ãããã³ãžã«ïŒã¢ããããšãã«ããšã¹ãã«âïŒâ
ãšãã«ãšã¹ãã«ãé»è²æ²¹ç¶ãIRïŒãã€ã«ã ïŒcm-
ïŒïŒ3340ã3020ã1685ã1615ã1525ã1350ããã
ïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒâ
ïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãžã«ã«ãã³
é žâïŒâãïŒâãâïŒïŒâã¯ãããã³ãžã«ïŒââ
ãïŒâïŒïŒâã€ãããŸãªã«ïŒãããã€ã«ãã¢ããã
ãšãã«ããšã¹ãã«âïŒâãšãã«ãšã¹ãã«ãåŸãã é»è²æ²¹ç¶ IRïŒãã€ã«ã ïŒcm-1ïŒ2930ã1690ã1625ã
1520ã1350 NMRïŒCDCl3ïŒÎŽå€ïŒ 0.90ã2.00ïŒ15HïŒïœïŒã2.38(s) 2.08ã2.68(m) 8Hã 3.20ã4.70ïŒ10HïŒïœïŒã5.13ïŒ1HïŒïœïŒã 6.68ã8.30ïŒ12HïŒïœïŒ 補é äŸ ïŒ (1) (E)âïŒâã¡ãã«âïŒâãïŒâïŒïŒâããªãžã«ã¡
ãã«ïŒããšãã«ãã¢ã¯ãªã«é žã»å¡©é žå¡©0.2ïœã
å¡©åããªãã«ïŒmlã«æº¶è§£ãããïŒïŒ®âãžã¡ã
ã«ãã«ã ã¢ããïŒæ»Žãå ããŠå ç±éæµäžã«ïŒæ
éåå¿ããããã€ãã§ãæžå§äžã«éå°ã®å¡©åã
ãªãã«ãçå»ããã°ã(E)âïŒâã¡ãã«âïŒâ
ãïŒâïŒïŒâããªãžã«ã¡ãã«ïŒããšãã«ãã¢ã¯ãª
ã«é žã¯ããªãã®å¡©é žå¡©ãæ®çç©ãšããŠåŸããã
ãããå¡©åã¡ãã¬ã³ïŒmlã«æº¶è§£ãããã (2) ïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããšã
ã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãž
ã«ã«ãã³é žâïŒâãšãã«ãšã¹ãã«âïŒâãïŒâ
ïŒïŒ®âã¡ãã«ã¢ããïŒãšãã«ããšã¹ãã«0.25ïœ
ãå¡©åã¡ãã¬ã³ïŒmlã«æº¶è§£ãããããã«æ°·å·
äžãïŒïŒ¯âãã¹ïŒããªã¡ãã«ã·ãªã«ïŒã¢ã»ã
ã¢ãã0.17mlãå ããŠå®€æž©ã§30åéæªæãã
ãã ã€ãã§ããã®åå¿æ¶²ã«ã(1)ã§åŸãããå¡©åã¡ã
ã¬ã³æº¶æ¶²ãâ10ãâïŒâã§æ»ŽäžããåŸã宀枩ã§ïŒ
æéåå¿ããããæžå§äžã«æº¶åªãçå»ããåŸãã
ãæ®çç©ã«é ¢é žãšãã«10mlããã³æ°Ž10mlãå ãã
1Nâæ°Žé žåãããªãŠã 氎溶液ãçšããŠPHïŒã«èª¿
æŽããææ©å±€ãååããããã®æº¶æ¶²ãæ°Ž10mlãã
ã³é£œåé£å¡©æ°Ž10mlã§é 次æŽæµããåŸãæžå§äžã«æº¶
åªãçå»ããåŸãããæ®çç©ãã«ã©ã ã¯ãããã°
ã©ãã€ãŒãåå ã·ãªã«ã²ã«ïŒ£â200ïŒæº¶åºæº¶åªã
ãã³ãŒã³ïŒé ¢é žãšãã«æ··å液ïŒå®¹éæ¯ïŒïŒïŒïŒã
ã§ç²Ÿè£œããã°ãé»è²ç²æ«ã®ïŒïŒïŒâãžã¡ãã«âïŒ
âïŒïŒâãããããšãã«ïŒâïŒïŒïŒâãžãããããª
ãžã³âïŒïŒïŒâãžã«ã«ãã³é žâïŒâãšãã«ãšã¹ã
ã«âïŒâãïŒâãâ(E)âãïŒâãïŒâïŒïŒâããªãž
ã«ã¡ãã«ïŒããšãã«ãã¡ã¿ã¯ãªãã€ã«ãââã¡
ãã«ã¢ããããšãã«ããšã¹ãã«0.17ïœïŒåç43.5
ïŒ ïŒãåŸãã IRïŒKBrïŒcm-1ïŒ2940ã1685ã1610ã1520ã
1345 NMRïŒCDCl3ïŒÎŽå€ïŒ 1.18ïŒ3HïŒïœïŒïŒªïŒïŒHzïŒã2.05ïŒ3HïŒïœïŒã 2.36ïŒ6HïŒïœïŒã3.01ïŒ3HïŒïœïŒã3.37ã4.60 ïŒ8HïŒïœïŒã5.15ïŒ1HïŒïœïŒã6.46ïŒ1HïŒbsïŒã 6.83ã8.80ïŒ13HïŒïœïŒ 補å€äŸ ïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããšãã«ïŒ
âïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãžã«ã«ã
ã³é žâïŒâãïŒâãâãã³ãžã«ââãïŒâïŒïŒâ
ã€ãããŸãªã«ïŒãããã€ã«ãã¢ããããšãã«ããš
ã¹ãã«âïŒâãšãã«ãšã¹ãã«2.5mgãå«æããé
å€ããäžèšæ·»å å€ãçšããŠãèªäœå ¬ç¥ã®æ¹æ³ã§èª¿
補ããã 10000é ã«ã€ããŠïŒ äžèšååç© 250ïœ ã»ã«ããŒã¹ 700ïœ ã©ã¯ããŒã¹ 780ïœ ããŠã¢ãã³ã·æŸ±ç² 700ïœ ã¹ãã¢ãªã³é žãã°ãã·ãŠã 20ïœ æ°Ž é©éã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžè¬åŒïŒ ãåŒäžãR1ããã³R7ã¯ãåäžãŸãã¯ç°ãªã€ãŠ
äœçŽã¢ã«ãã«åºãïŒR2ããã³R3ã¯ãåäžããã
ã¯ç°ãªã€ãŠãæ°ŽçŽ ååãããã¯äœçŽã¢ã«ãã«ãã¢
ãªãŒã«âäœçŽã¢ã«ãã«ãããã²ã³çœ®æã¢ãªãŒã«â
äœçŽã¢ã«ãã«ãã¢ãªãŒã«ãŸãã¯ããšãã«åºãïŒ
R4ã¯ã眮æãããŠããŠããããçªçŽ ååãå°ãª
ããšãïŒã€ä»¥äžå«ãïŒå¡ãŸãã¯ïŒå¡è€çŽ ç°åŒåº
ãïŒ5ã¯ã眮æãããŠããŠãããããšãã«åºãïŒ
R6ã¯ãäœçŽã¢ã«ã³ãã·ã«ã«ããã«ãäœçŽã¢ã«ã³
ãã·âäœçŽã¢ã«ã³ãã·ã«ã«ããã«ãŸãã¯ïŒ®âã¢ãª
ãŒã«âäœçŽã¢ã«ãã«ââäœçŽã¢ã«ãã«ã¢ããâ
äœçŽã¢ã«ã³ãã·ã«ã«ããã«åºãïŒïŒ¡ã¯ãã¢ã«ãã¬
ã³ãŸãã¯ã¢ã«ã±ãã¬ã³åºãïŒïŒ¢ã¯ãè³éŠæçåæ°Ž
çŽ ç°ïŒäŸ¡åºãŸãã¯çµåæãïŒïŒ€ã¯ãã¢ã«ãã¬ã³åº
ãŸãã¯çµåæãïŒããã³ïœã¯ãïŒïŒïŒïŒïŒãŸãã¯
ïŒããããããæå³ãããã ã§è¡šããããïŒïŒïŒâãžãããããªãžã³èªå°äœã
ãã³ãã®å¡©é¡ã
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7236684A JPS60215684A (ja) | 1984-04-11 | 1984-04-11 | æ°èŠãªïŒïŒïŒâãžãããããªãžã³èªå°äœããã³ãã®å¡©é¡ |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7236684A JPS60215684A (ja) | 1984-04-11 | 1984-04-11 | æ°èŠãªïŒïŒïŒâãžãããããªãžã³èªå°äœããã³ãã®å¡©é¡ |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60215684A JPS60215684A (ja) | 1985-10-29 |
JPH053467B2 true JPH053467B2 (ja) | 1993-01-14 |
Family
ID=13487237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7236684A Granted JPS60215684A (ja) | 1984-04-11 | 1984-04-11 | æ°èŠãªïŒïŒïŒâãžãããããªãžã³èªå°äœããã³ãã®å¡©é¡ |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60215684A (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6147477A (ja) * | 1984-08-14 | 1986-03-07 | Kowa Co | æ°èŠïŒïŒïŒâãžãããããªãžã³âïŒïŒïŒâãžã«ã«ãã³é žãšã¹ãã«èªå°äœ |
-
1984
- 1984-04-11 JP JP7236684A patent/JPS60215684A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS60215684A (ja) | 1985-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5603849B2 (ja) | ã¢ããã¢ã«ãã«ãã³ãŸã€ã«âãã³ãŸãã©ã³ãŸãã¯ãã³ãŸããªãã§ã³èªå°äœãå«ãå»è¬çµæç© | |
KR100413985B1 (ko) | ìë¡ìŒ-íŒí늬ëì ë첎 | |
JPS6341903B2 (ja) | ||
JP3419009B2 (ja) | çž®åãã³ãŒã³ãªãã·é ¢é žèªå°äœããã³ããããæå¹æåãšããŠå«æããè¬å€ | |
JP3179599B2 (ja) | çž®åãã³ãŒã³ãªãã·é ¢é žèªå°äœããã³ããããæå¹æåãšããŠå«æããè¬å€ | |
JPH0673038A (ja) | ããã§ãã«èªå°äœããããã®ååç©ãå«ãå»è¬çµæç©åã³ãããã®èª¿è£œæ³ | |
HU211680A9 (en) | Pyrazolopyridine compounds which have useful pharmaceutical utility | |
JP2000511173A (ja) | äžé žåçªçŽ ç£çé»å®³å€ãšããŠã®æ°èŠãªã€ã³ããªã«ããã³ãã³ãŸãã©ãã«ã«ã«ãããµãã | |
JP3341019B2 (ja) | éžæçãã€ã³ããªãšã³ïœâ²ïŒâŒæ®æå€æŽ»æ§ã瀺ã眮æãããåç°åŒã¢ãªãŒã«ååç© | |
US4857644A (en) | Aryl sulfonopiperazines as anti-inflammatory agents | |
JPS6013788A (ja) | æ°èŠãªã¯ããªã³èªå°äœ | |
JP2691679B2 (ja) | ãªãã·ã èªå°äœããã³ãããå«æããå»è¬å | |
FR2566404A1 (fr) | Nouveaux derives de la 1,4-dihydropyridine, leurs sels, procede pour les preparer, et compositions pharmaceutiques les contenant | |
EP0579059B1 (en) | Pyridazinone derivatives and processes for preparing the same | |
SU867304A3 (ru) | СпПÑПб пПлÑÑеМО пÑПОзвПЎМÑÑ N-ÑеМОл-N-(4-пОпеÑОЎОМОл)аЌОЎа ОлО ÐžÑ ÑПлей | |
JPH053467B2 (ja) | ||
EP0718307A2 (fr) | Dérivés de 1-oxo-2-(phénylsulfonyl-amino)pentylpipéridine, leur préparation et leur application en thérapeutique | |
JPH01216961A (ja) | ïŒïŒâãªããã·ã²ããŒã¹é»å®³å€ | |
JPS63225354A (ja) | ã¢ãŒããžãã³èªå°äœ | |
JPS6347710B2 (ja) | ||
JPH02193965A (ja) | æ°èŠãªïŒâããã²ã³çœ®æïœâã€ã³ããªã«ãšãã«âã¹ã«ãã³ã¢ããããããã®è£œé æ¹æ³ãåã³è¬ç©ã«ããããããã®äœ¿çš | |
JPH0564150B2 (ja) | ||
KR800001591B1 (ko) | 1, 4-ëíìŽëë¡ íŒëŠ¬ë ì ë첎ì ì ì¡°ë°©ë² | |
JPH06279389A (ja) | ã¢ããžããã§ãã«ãšãŒãã«èªå°äœ | |
JPH0725854A (ja) | çž®åãã³ãŒã³ãªãã·é ¢é žèªå°äœ |